Longitudinal gene networks, canonical pathways and functional analysis of microarray data from Longissimus thoracis et lumborum muscle samples of early-weaned Angus steers by Moisa, Sonia
  
 
 
 
LONGITUDINAL GENE NETWORKS, CANONICAL PATHWAYS AND FUNCTIONAL 
ANALYSIS OF MICROARRAY DATA FROM LONGISSIMUS THORACIS ET 
LUMBORUM MUSCLE SAMPLES OF EARLY-WEANED ANGUS STEERS 
  
 
 
 
 
BY 
 
SONIA JOSEFINA MOISÁ 
 
 
 
 
 
 
 
 
THESIS 
 
Submitted in partial fulfillment of the requirements 
for the degree of Master of Science in Animal Sciences 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2011 
 
 
 
 
Urbana, Illinois 
 
 
 
 
 Adviser: 
 
  Associate Professor Juan J. Loor
II 
 
ABSTRACT 
Metabolic regulation in complex organisms relies partly on transcriptional control of 
gene networks as a long-term mechanism affecting the level of expression of several key 
enzymes. Objectives were to evaluate temporal gene expression profiles in Longissimus 
thoracis et lumborum of early-weaned (155 ± 10 d age at weaning) Angus steers (n = 7/diet) 
fed a high-starch (HiS, NEG = 5.98 MJ/kg diet dry matter) or low-starch (LoS, NEG = 4.97 
MJ/kg) diet for 120 d, at which point all steers were switched to a common feedlot diet until 
slaughter. Muscle samples biopsies for transcript profiling were collected at 0, 60, 120, and 
220 d of feeding. A 13,153 bovine oligonucleotide (70-mers) array was used for transcript 
profiling. Canonical pathways analysis was performed by means of the Kyoto Encyclopedia 
of Genes and Genomes (KEGG) and functional analysis was performed by the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) bioinformatics software’s. 
ANOVA using a false discovery rate < 0.01 revealed ca. 4,300 differentially expressed genes 
(DEG) due to time. During the growing phase, the most prominent differences occurred at 60 
vs. 0 days when a total of 1,934 DEG were observed. The number of DEG due to time, 
however, was 4,032 at 220 vs. 0 days. Pentose and glucuronate interconversions, Sulfur 
Metabolism, Steroid biosynthesis and PPAR Signaling Pathway were the most recurrent 
KEGG significant pathways for this microarray analysis. KEGG pathway results were in 
accordance with the metabolic processes that were expected to happen during the growing 
and finishing periods. DAVID significant lipid-related biological processes highlighted a lack 
in LDL receptors during the growing phase. Steroid synthesis could be used as a sign of 
production of LDL that contain cholesterol; moreover, the upregulation of the carnitine 
shuttle and the biosynthesis of acylglycerols also are signals for lipogenesis during the 
finishing phase. DAVID gene expression-related most impacted biological process was the 
circadian regulation of gene expression. Genes that showed significant expression are 
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evidence for genetic-related regulation of feed intake mainly during the finishing phase 
period. 
A second study was conducted to test the effect of early weaning (EW) (140 ± 6 days 
after birth) compared to steers that were normal weaned (218 ± 6 days after birth) with corn-
based creep supplement (NW), and normal weaning with no creep feeding (CON). In this 
study, a transcription regulators analysis was performed. As a result, Yin Yang 1 (YY1) was 
the transcription regulator that affected the greatest number of molecules (126 genes). Within 
these affected genes with direct and indirect connection to YY1 gene, Insulin Growth Factor 
Binding Protein 5 (IGFBP5), Signal transducer and activator of transcription 5B (STAT5B), 
General Transcription Factor 2B (GTF2B), and K(lysine) acetyltransferase 2B (KAT2B), 
were the genes which showed to have a role on myogenesis and adipocyte differentiation. 
The outcome of this study was that the administration of starch in the diet of early weaned 
steers early in life, was expressed in higher scores for intramuscular fat deposition compared 
with normal weaned steers that received and did not receive creep feeding. Although, there 
was not a direct effect of YY1 as a regulator of adipocyte differentiation, there were indirect 
effects by means of YY1 target genes. IGFBP5 which is both PPAR- and VDR- target gene 
presented a role as an enhancer of adipocyte differentiation. This was noticeable in early 
weaned steers by IGFBP5 expression that enhanced the release of IGF-1 which stimulates 
adipocyte differentiation. Results revealed marked adaptations in networks and pathways 
during rapid growth of skeletal muscle. 
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CHAPTER 1: LITERATURE REVIEW 
This literature review details current understanding of mesenchymal stem cell 
commitment to the adipose lineage and the subsequent differentiation of preadipocytes into 
adipocytes. Also, all the aspects of lipid metabolism will be taken into account. Moreover, a 
short description of the advantages of the use of early weaning and creep feeding management 
techniques in beef production systems is included. Finally, microarray analysis is described as a 
way to measure the expression levels of a large amount of genes simultaneously. 
ADIPOGENESIS 
The primary role of adipocytes is to store energy in the form of triacylglycerol (TAG) 
during times when input exceeds expenditure and to break down these stored lipids into free fatty 
acids (FFA) when energy is required.  The process of generation of a mature adipose cell 
consists of five different steps: determination, commitment, growth arrest, mitotic clonal 
expansion and differentiation. 
Determination and Commitment 
The adipose lineage arises from a multipotent stem cell population of mesodermal origin. 
These precursor cells exist in the vascular stroma of adipose tissue and undergo a process that 
begins with an initial commitment step, in which cells become constrained to the adipocyte 
lineage, and a subsequent program of activation of transcription regulators resulting in the 
appearance of the adipocyte shape. Determination results in the conversion of the mesenchymal 
stem cell to a pre-adipocyte that has lost the potential to differentiate into other cell types. The 
factor responsible for signaling the conversion of multipotent stem cells to the adipocyte lineage 
is unknown. It is thought that mature adipocytes secrete unknown factors that promote 
preadipocyte proliferation and differentiation (Considine et al. 1996). 
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Growth Arrest and Mitotic Clonal Expansion 
In cell culture, preadipocytes become cell density inhibited and arrest at the G0/G1 cell 
cycle state line. Growth-arrest is necessary for preadipocyte differentiation (Gregoire et al. 
1998). Cells that have progressed down the differentiation way can no longer divide. Growth 
arrested cells receiving the appropriate combination of mitogenic and adipogenic signals will 
synchronously reenter the cell cycle and undergo several rounds of mitosis steps of cell division, 
referred to as mitotic clonal expansion, where DNA replication and chromatin structure changes 
occur (MacDougald and Lane 1995), leading to the increase in the final proportion of the 
differentiated fat cells. C/EBPα over-expression by means of the interaction with cyclin-
dependent kinases 2 and 4 prevents cycling binding and produces cell cycle arrest, which stops 
the mitotic clonal expansion step of adipogenesis (Umek et al. 1991; Wang 2001). 
Differentiation 
Differentiation of preadipocytes into adipocytes leads to the expression of several 
downstream adipocyte is included genes leading to an increased capacity of the cell to transport 
large amounts of glucose in response to insulin (more insulin sensitive) to synthesize fatty acids 
for triacylglycerol assimilation and deposition of intracellular fat globules. Once differentiation 
begins, preadipocytes experience a number of changes that consist of reduction of the collagen 
synthesis, changes in the type of cell-matrix adhesion molecules, and changes in the intracellular 
proteins responsible for the size and shape of the mature adipocytes (Smas and Sul 1995). The 
reorganization of extracellular matrix and cytoskeleton proteins makes the fat cells to adopt a 
rounded morphology and accumulate lipids in the cytoplasmic vesicles, which are the main 
features of a mature adipocyte. Also, terminal differentiation makes adipocytes start working as a 
secretory cell of molecules such as leptin, adiponectin, cytokines, and others (Bray 2004). The 
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mouse 3T3-L1 and 3T3-F442A lines are the most extensively characterized preadipocyte cell 
lines due to their ability to accumulate cytoplasmic TAG (Green and Kehinde 1974). 
Differentiation of adipocyte precursors results from a cascade of transcription regulators, 
coactivators, and cell-cycle receptors. Mediators which are competent inducers of adipocyte 
differentiation include: insulin, insulin-like growth factor-1 (IGF-1), glucocorticoid, 
triiodothyronine, and cyclic AMP (cAMP) (Spiegelman and Green 1980). However, these agents 
are most effective when they are used in combination (Student et al. 1980). The master regulator 
of adipocyte differentiation is peroxisome proliferator-activated receptor gamma (PPARG), a 
member of the nuclear- receptors superfamily which is both necessary and sufficient to generate 
adipogenesis (Rosen et al. 2002). 
Preadipocytes can be induced to differentiate by means of an external cue like insulin, 
glucocorticoids or agents that leads to an increase in cAMP. This cue triggers the beginning of a 
transcriptional cascade composed of all the proteins that mediates the adipocyte function. Several 
CCAAT/enhancer-binding proteins (C/EBPs) are important adipogenic and lipogenic 
transcription factors. They are expressed in a cascade with early induction of C/EBPB and 
C/EBPD leading to induction of C/EBPA. C/EBPA is a transactivator of PPARG, both 
transcription regulators act together to promote adipogenesis. C/EBPA cannot function 
efficiently if PPARG is not present. In differentiated adipocytes C/EBPA is needed for insulin 
sensitivity but it is not required for lipid accumulation or the expression of many adipocyte genes 
(Wu et al. 1999). C/EBPG and CHOP-10 (transcriptional factor homologous to CCAAT-
enhancer binding protein) suppress adipogenesis by heterodimerization with, and inhibition of 
C/EBPA (Batchvarova et al. 1995; Darlington et al. 1998). 
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During early stages of adipogenesis, the helix-loop-helix protein, adipocyte determination 
and differentiation-dependent factor-1/sterol regulatory element-binding protein-1 (ADD-
1/SREBP-1) exerts its function of induction of PPARG expression (Fajas et al. 1999) and 
production of endogenous PPARG ligands required for transcriptional activity (Spiegelman et al. 
1998). 
Krüppel-like transcription factors (KLF) is a large family of C2H2 zinc-finger proteins 
important in adipogenesis that regulate apoptosis, proliferation and differentiation. C/EBPB and 
C/EBPD induce pro-adipogenic KLF5 which directly bind to PPARG promoter enhancing 
adipocyte differentiation, including expression of the solute carrier family 2 (facilitated glucose 
transporter), member 4 (SLC2A4), which is an insulin-sensitive glucose transporter previously 
known as GLUT4, and that also produce the inhibition of Delta like-1/Preadipocyte factor - α 
(Dlk-1/Pref-1) expression by relocation of the anti-adipogenic KLFs (KLF2 and KLF7) from cis 
regulatory sites (Wu et al. 2005). 
LIPID METABOLISM 
In ruminants, the breakdown of dietary lipids by rumen bacteria is essentially a complete 
process, where little monoglycerides or diglycerides pass to the lower digestive tract (Drackley 
2004). The primary site for absorption of fatty acids (FA) is the small intestine. However, the 
profile of the FA that reaches the small intestine varies compared with those from the diet. 
Rumen biohydrogenation is a process that the anaerobic bacteria performs to manage the 
concentration of unsaturated FA, which are toxic for them (Maia et al. 2010). In the liver, FA 
experience β-oxidation producing ketone bodies, which are exported into the circulation. In the 
intestine, the mechanism of absorption of these FA is the formation of a micelle, which is a bi-
layer membrane consisting of bile salts, phospholipids, and the insoluble lipids in the middle. 
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After absorption of FA into the enterocytes, FA are reconverted to TAG. The TAG are packaged 
into lipoprotein particles called chylomicrons or VLDL, in combination with cholesterol, 
phospholipids, and specific proteins. These proteins, so called apolipoproteins, serve to direct the 
trafficking and use of the lipoprotein TAG. The apolipoproteins are not small enough to pass into 
the venous blood stream draining the intestinal cells; they are secreted into the lymph, which is 
delivered back into the blood stream. TAG in chylomicrons or VLDL are broken down to FFA 
by an enzyme called lipoprotein lipase (LPL). Then, the FFA enter the adipose cells, and they are 
synthesized back into TAG, forming the lipid droplets (Bauman 2003).  
Fatty Acid Synthesis 
The main product of fatty acid synthesis is palmitic, oleic and stearic acids. The 
proportion of the various fatty acids formed varied with the age and the adipose tissue depot 
(Pothoven et al. 1974), and also the concentration of acetate used (Deeth and Christie 1979). The 
rate of fatty acid synthesis could be influenced by the acetate, glucose, lactate, pyruvate, 
NADPH, NADH and ATP concentration or by the presence of fat in the diet (Hood 1972). Lipid 
metabolism is affected by the hormones involved in energy regulation. Insulin and 
catecholamines have short term effects, while growth hormone, thyroid hormone and 
glucocorticoids operates over longer periods of time. Insulin stimulates fat storage by increasing 
lipogenesis or by activation of circulation TAG uptake.  
In adipose tissue from cattle, acetate increased the effect of insulin on the rate of glucose 
oxidation by increase the affinity of the tissue for glucose (Mears and Mendel 1974; Yang and 
Baldwin 1973a). In vitro, insulin stimulate the incorporation of acetate into fatty acids in the 
adipose tissue from cattle (Baldwin and Smith 1971; Yang and Baldwin 1973b). Larger fat cells 
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have more difficulty responding to insulin than smaller ones, hence they are more insulin 
resistant. Insulin inhibits lipolysis by reducing fat mobilization and stimulating re-esterification 
of FA by enhancing the synthesis of LPL, VLDL and chylomicron to adipose capillaries. More 
FA are released into the blood streams with the decrease of insulin levels. If insulin resistance is 
reduced in larger fat cells, it will be more FA release and lower release from smaller “insulin-less 
resistant” fat cells, hence, adipocyte cell size distribution tends to normalized over time.  
Carbon Source 
Adipose tissue is the major site of fatty acid synthesis in the non-lactating ruminant. 
Acetate and glucose are the principal precursors for fatty acid synthesis in adipose tissue. Acetate 
carbon use for fatty acid synthesis is more efficient than glucose carbon (Baldwin et al. 1973). In 
fetal stages, glucose carbon is also used for fatty acid synthesis in ruminant adipose tissue 
(Bassett 1977; Battaglia and Meschia 1978). The production of fatty acid from lactate carbon 
source involves two enzymes (Acetyl CoA Carboxylase and Fatty Acid Synthase) and it 
represents 38% of that of acetate (Prior 1978). The rate of fatty acids synthesis from pyruvate 
was 3-fold greater than the rate from glucose (Prior and Jacobson 1979). The production of odd-
numbered and branched-chain fatty acids biosynthesis is made when propionate and 
methylmalonate were utilized, but this kind of fatty acids are not normally found in ruminant 
tissues because they are converted to glucose in the liver, leaving little to reach adipose tissue 
(Hood 1972). Finally, butyryl CoA and β-hydroxybutyryl CoA can replace Acetyl CoA as 
primers for fatty acid synthesis but only in ruminant mammary gland (Moore and Christie 1979). 
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Hydrogen Source 
The pentose phosphate pathway provides an important amount of NADPH that it is a 
requisite for fatty acid synthesis (Kather and Brand 1975). The principal enzymes of NADPH 
production within the cytosol are glucose-6-phosphate dehydrogenase, 6-phosphogluconate 
dehydrogenase, NADP-malate dehydrogenase and NADP-isocitrate dehydrogenase (Baldwin et 
al. 1969; Baldwin et al. 1973; Hanson and Ballard 1967; Howarth et al. 1968). Glucose appears 
to be oxidized via the pentose phosphate pathway in bovine adipocytes in absence of acetate; 
hence, in the absence of fatty acid synthesis (Yang and Baldwin 1973b). The NADP-malate 
dehydrogenase has a minor role in NADPH production in adipose tissue. The low rate of glucose 
conversion to fatty acids and the low activity of ATP-citrate lyase suggest that the citrate-
oxaloacetate-malate-pyruvate sequence is of little significance in ruminants (Vernon 1980). 
The translocation of citrate from the mitochondria requires the simultaneous uptake of 
malate by the mitochondria, requiring the dicarboxylic acid translocase system, which will 
exchange malate for phosphate (Klingenberg 1970). However, the malate thus transferred to the 
cytosol could also be metabolized to oxaloacetate by NAD-malate dehydrogenase, with the 
related production of NADH. Hence, NADH production may dominate the metabolism of malate 
in the cytosol of ruminant adipose tissue (Vernon 1980). 
NADP-isocitrate dehydrogenase is the most active of the NADP-linked dehydrogenases 
in the cytosol of ruminant adipose tissue. The pathway for NADPH production starts with the 
translocation to the cytoplasm of the isocitrate produced in the mitochondria, as 2-oxoglutarate. 
Within the mitochondria, the 2-oxoglutarate can be directly reduced to citrate via isocitrate, or it 
can be metabolized via the TCA cycle (Vernon 1980). 
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Enzymes 
There are a important group of enzymes that regulates lipid metabolism. between them. 
Acetyl CoA synthetase is a cytosolic enzyme reported to be present in adipose tissue (Buchanan-
Smith et al. 1973; Hanson and Ballard 1967). A combination of mitochondrial Acetyl CoA 
hydrolase activity and cytoplasmic Acetyl CoA synthetase could provide a mechanism for 
transferring Acetyl CoA units from mitochondria to the cytoplasm (Lowenstein 1963), but its 
role in the ruminant is unclear. The enzyme Acetyl CoA Carboxylase (ACC) catalyzed the 
conversion of Acetyl CoA to Malonyl CoA using Biotin as a cofactor. It has an allosteric control 
by the enzyme cAMP-activated protein kinase (AMPK) that phosphorylates it, leading to the 
inactive protomeric form, and by the enzyme phosphatase (upregulated by the insulin presence) 
that leads ACC to its active polymeric form (Moss et al. 1972). ACC was a rate limiting role in 
determining the fatty acids synthesis (Kim et al. 1989). The conversion to the active state of 
ACC is stimulated by citrate and other tricarboxylic acids whereas reversal to the inactive form 
is promoted by malonyl CoA and long-chain fatty acyl CoA esters (Kleinschmidt et al. 1969). 
Fatty Acid Synthase is an enzyme complex involved in the conversion of acetate to palmitate or 
longer chain fatty acids (Smith et al. 2003). Pyruvate Dehydrogenase is a mitochondrial enzyme 
that its interconverted by specific phosphatase and kinase to its active dephosphorylated state 
(Denton et al. 1975). It has a low activity in ruminant adipose tissue, explained by the high 
lactate output by the tissue (Yang and Baldwin 1973b). The lactate released from ruminant 
adipose tissue would be reconverted to glucose by the Cori cycle (Reilly and Chandrasena 1978), 
and it also account for the low rate of glucose oxidation via the tricarboxylic acid cycle which is 
thought to occur in ruminant adipose tissue. Citrate synthase enzyme catalyzes the condensation 
reaction of the two-carbon acetate residue from acetyl coenzyme A and a molecule of four-
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carbon oxaloacetate to form the six-carbon citrate (Wiegand and Remington 1986). The reason 
for the low rate of utilization of glucose for fatty acid synthesis in ruminant adipose tissue is the 
low level of ATP-citrate lyase (Hanson and Ballard 1967) that later on, it was confirmed to be 
high in ruminant adipose tissue (Smith and Prior 1981). 
Synthesis of Glycerol 3-phosphate 
Glycerol 3 – phosphate is required for fatty acid esterification. This may be synthesized 
from glucose (major precursor) via the glycerol 3 – phosphate dehydrogenase reaction, from 
glycerol by the action of glycerol kinase (low activity in ruminants), or from other metabolites by 
gluconeogenesis. The rate of glycerol 3 – phosphate synthesis may be determined by the 
availability of glucose, insulin and long-chain fatty acyl CoA esters. NADH availability also 
regulates glycerol 3-phosphate synthesis, because it is required for the reduction of dihydroxy-
acetone-phosphate to glycerol 3 – phosphate. In ruminant adipose tissue, there is no net 
production of NADH because most of the glucose metabolized via the glycolytic pathway is 
released from the cell as lactate. Therefore, NADH must be derived from another source, most 
probably by the efflux of malate from the mitochondria (Yang and Baldwin 1973b). In ruminant 
adipose tissue, NAD-malate dehydrogenase is very active (Baldwin et al. 1973), hence, malate 
that leaves the mitochondria appears to be sufficient to maintain a high NADH:NAD ratio in the 
cytosol (Vernon 1980). 
Fatty Acid Metabolism 
Fatty acids are synthesized from acetate. Acetate oxidation is probably the major source 
energy for adipose tissue. Palmitic acid oxidation is produced in less quantity than the rate of 
acetate oxidation, but it is more efficient in ATP production (129 vs. 11 moles of ATP 
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respectively) (Baldwin et al. 1973). Desaturation of fatty acids occurs due to the exposure to the 
microsomal desaturase system that desaturates stearic acid in preference to palmitic acid. Fatty 
acids synthesized de novo are readily desaturated in ruminant adipose tissue (Pothoven et al. 
1974; Wahle 1974). The presence of fatty acid chain elongating activity was demonstrated in 
ruminant adipose tissue, resulting in 45 to 55% of fatty acids elongated from C-16 to C-18 fatty 
acids (Pothoven et al. 1975). Little is known about the process of esterification in ruminant 
adipose tissue (Benson and Emery 1971). The microsomal diacylglycerol acyltransferase 
(DGAT) found in adipose tissue acylates microsomal bound 1,2 dipalmitylglycerol with acyl 
CoAs of chain length from C4 to C18 (Marshall and Olefsky 1979). The rate of esterification is 
markedly influenced by age, sex, breed, lactation and feeding a low roughage diet (Faulconnier 
2007). 
Lipolysis 
The storage and release of TAG and FA are coordinately regulated to store lipid fuels 
during the immediate postprandial periods and release them during periods of fasting. This 
energy metabolism is regulated by lipoprotein lipase (LPL) and hormone sensitive lipase (HSL). 
The hydrolytic cleavage of the TAG to FFA and glycerol is required for mobilization and use of 
adipose tissue lipids. The rate limiting step of this process is the initial cleavage of TAG to DAG, 
which is catalyzed by HSL. The DAG is then hydrolyzed by additional lipases usually resulting 
in the complete hydrolysis of the TAG to FFA and glycerol (Shapiro 1977). The rate of lipolysis 
depends on the amount of the cytosolic enzyme HSL present and the proportion of this enzyme 
in its active form. The activation of the HSL involves its phosphorylation by a cyclic AMP-
dependent protein kinase, while the conversion of the active enzyme to the inactive state is 
catalyzed by a phosphatase (Robinson and Sutherland 1971; Shapiro 1977). Perilipin A protects 
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the neutral lipid core of the particle from degradation. Phosphorylation of both Perilipin A and 
HSL is crucial for the translocation of HSL to the surface of lipids where it catalyzes the release 
of FA from TAG (Ali et al. 2005). Catecholamines are usual activators of HSL, by activation of 
adenylate cyclase located in the cell membrane. Infusions of the catecholamines adrenalin or 
noradrenalin into ruminants result in an instantaneous increase in the plasma FFA 
concentrations. The indicator of changes in the rate of lipolysis is the changes in plasma FFA 
concentrations resulting from the inhibition or activation of the adipose tissue HSL-mediated 
lipolysis and the facilitated uptake of chylomycrons or VLDL. During the fasting state, adipose 
tissue LPL activity is down-regulated, and muscle LPL is up-regulated, insulin levels are low, 
HSL is activated, and catecholamine-stimulated adipose tissue lipolysis is active. As a result, 
FFA is released from fat, plasma FFA concentrations rise, and muscle uptake of FFA increases. 
The FFA concentration also increases during fasting, contributing energy for hepatic 
gluconeogenesis and ketogenesis. During longer periods of fasting, FFA becomes the major fuel 
in organs where glucose is not a required fuel (Yu and Ginsberg 2005). The innervation of white 
adipose tissue by the sympathetic nervous system (SNS) is the source of noradrenalin, which 
regulates the process of lipid mobilization (Bartness and Bamshad 1998). 
After a meal, dietary TAG is digested by pancreatic lipase in the small intestine and 
absorbed by the enterocytes as free fatty acids (FFA) or monoacylglycerols (MAG) (Phan and 
Tso 2001).  The TAG reassembled are exported into the circulation as chylomicrons. In the fed 
state, adipose tissue is the major site for uptake of dietary MAG and FFA, after LPL-mediated 
hydrolysis of chylomicrons. LPL binds to proteoglucans at the luminal space of the capillary 
blood epithelium of the muscle and adipose tissue, where it interacts with TAG-rich lipoproteins 
(Goldberg 1996) and, in the presence of apoCII, hydrolyzes TAG. ApoCIII inhibits LPL-
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mediated TAG hydrolysis, and the ratio of apoCII to apoCIII may be critical in regulating dietary 
delivery of TAG to adipose tissue (Shachter 2001). 
During lipolysis, the FFA released has to be trapped in the adipose tissue to prevent high 
plasma FFA concentration in the tissues that they not need FFA as an energy source (Fielding 
and Frayn 1998). A gradient for FA uptake is produced by inhibition of HSL-mediated TAG 
lipolysis during the hyperinsulinemic postprandial period and an efficient acylation of the FFA 
that just arrived inside the adipocyte cells. Acylation-stimulating protein (ASP) or Adipsin is the 
molecule that regulates these functions (Faraj et al. 2004). Adipsin increased glucose uptake, 
essential for glycerol formation, and the activity of diacylglycerol acyltransferase (DGAT), 
enhancing in this way the availability of FFA for TAG synthesis. Almost all the LPL-released 
FFA are trapped by adipocytes after a meal, as a result of these lipid metabolism processes 
(Evans et al. 2002).  
Insulin is the principal antilipolytic hormone in ruminants because it inhibits adipose 
HSL through inhibition of its phosphorylation (Anthonsen et al. 1998), through increasing the 
activity of the phosphodiesterase or by inhibiting adenylate cyclase activity (Lambert et al. 1978; 
Shapiro 1977). The administration of insulin resulted in a fast decrease in plasma FFA (Bauman 
1976) and glycerol (Bergman 1968) levels. Insulin reduced the effect of adrenalin on the rate of 
lipolysis by 20-30% in adipose tissue from steers (Yang and Baldwin 1973a). Insulin can reduce 
the rate of fatty acid release from adipose tissue by stimulating glucose uptake and hence, fatty 
acid reesterification (Vernon 1980). Under conditions of insulin resistance, LPL and HSL 
responses are blunted; hence, trapping of dietary energy is inefficient both because of decreased 
LPL-mediated lipolysis of chylomicrons and ineffective inhibition of HSL-mediated lipolysis in 
adipose tissue (Coppack et al. 1992). 
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Growth hormone is thought to be lipolytic in ruminants because it may antagonize the 
action of insulin to maintain the levels of lipogenic enzymes (Wallace and Bassett 1966). 
Usually, administration of growth hormone resulted in an increase in plasma FFA levels and an 
increase in palmitate entry rate (Head et al. 1970). Protein synthesis in adipose tissue is required 
for the effects of growth hormone on lipolysis and it is thought that it may increase the amount of 
adenylate cyclase, which is involved in the activation of HSL (Robinson and Sutherland 1971). 
The degree of fatness in beef cattle has been positively correlated with serum insulin and 
glucocorticoid concentration, and negatively correlated with serum growth hormone 
concentration (Trenkle 1978). 
Glucose and glucose precursors such as propionate and glycerol can also decrease the 
plasma FFA levels (Menahan et al. 1966a). The effects of glucose on plasma FFA levels were 
increased by insulin (Pelkonen et al. 1968). Glucose also decreases the rate of lipolysis in the 
presence of catecholamines, but not the basal rate of lipolysis in adipose tissue from steers (Yang 
and Baldwin 1973a). The stimulation of re-esterification in vitro leads to a glucose-dependent 
TAG production. The effects of glucose on glycerol entry rate in vivo could be explained by a 
stimulation of insulin release, but it is probable that glucose has a more direct effect on lipolysis 
(Vernon 1980). 
The effect of β-hydroxybutyrate on lipolysis depends on its concentration . In vitro 
studies showed an inhibition of cyclic AMP formation, resulting in the reduction of the rate of 
FFA and glycerol release from bovine adipose tissue (Metz and van den Bergh 1972). β-
hydroxybutyrate had no effect on the basal rate of lipolysis, but it enhanced the rate of lipolysis 
in the presence of adrenaline on bovine adipocytes (Yang and Baldwin 1973a). In contrast, in 
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vivo studies showed that β-hydroxybutyrate inhibits lipolysis during ketosis in goats (Menahan 
et al. 1966b). 
MARBLING 
Marbling content is the intramuscular fat deposition that is composed of adipocyte 
clusters surrounded in a connective tissue matrix in close proximity to a blood capillary network 
(Harper and Pethick 2004). Mature marbling adipocytes are roughly spherical cells, smaller (40-
90 µm) than other fat depots (Cianzio et al. 1985; May et al. 1994). The intramuscular fat 
development varies chronologically, for example, Longissimus dorsi marbling appears earlier 
than in Pectoralis muscle (Cianzio et al. 1985). Also, genes involved in adipogenesis have 
different levels of expression according with the fat depot (Pickworth et al. 2011) and the animal 
breed (Taga et al. 2011). During postnatal growth, there is a replacement of fat cells due to 
formation of new ones from stem cells and lose of the older ones due to apoptosis (Leibel et al. 
1989). During the fattening period, there is a switch of nutrient utilization from muscle and 
skeletal growth to fat deposition due to an increase in the anabolic capacity of the adipose cells 
(Vernon 1980). 
Marbling is a macroscopically- delayed trait compared with the beginning of its 
deposition (Wegner 1998). Breeds with high potential for marbling deposition (e.g., Aberdeen 
Angus), have bigger mean diameter of adipocytes (P<0.001) resulting in a lower adipocyte 
density (cell number/mm2) (Pickworth et al. 2011). Of the two main carcass quality fat depots,  
intramuscular fat had smaller adipocytes and greater cell density compared with subcutaneous fat 
depots (Pickworth et al. 2011). Changes in the energy content of the diet influence the size of the 
adipocytes (Morris and Zemel 2005). Switching steers from a low-energy to a high-energy diet, 
and vice versa, resulted in an increased and decreased activity of lipogenic enzymes, with Acetyl 
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CoA Carboxylase the enzyme more affected due to these abrupt changes in the energy content of 
the diet (Yeh et al. 1980). 
Compared to bone and muscle, ruminant fat deposition does not reach maximum 
development in adult life but continued to develop with age (Hood and Allen 1973). The same 
occurs with blood capillaries of muscle and adipose tissue (Crandall et al. 1997), which are in 
close proximity to each cell and provide blood for delivery of metabolic substrates and 
elimination of cellular metabolic products.  
EARLY WEANING 
At birth and for around 25 days afterwards, calves depend exclusively on their mother's 
milk and so these young ruminants are in effect non-ruminants (Noble 1980). Milk is a 
particularly nutritious feed, compared with forages, and during the first 3-4 weeks of life, there is 
a rapid development of both total muscle mass and adipose tissue (Vernon 1980). During the 
growing phase, which is the period that follows after weaning, nutrients are partitioned in favor 
of skeletal and muscle growth while the rate of fat deposition is relatively low.  In contrast, 
during the finishing phase fat deposition was the highest response due to finishing rations. Body 
growth and fat deposition is influenced by how the animal is weaned. 
Early weaning systems encourage the calves to eat dry feed sooner. Calves can be 
weaned successfully at 4 to 5 weeks of age if they receive good management. An adaptation 
period is required, starting by offering to the calf a small amount of good quality starter right 
after feeding milk. The starter should have high protein content (18 to 20% of dry matter) and 
sweeteners like molasses added to obtain a better palatability, improve the intake and reduce the 
dustiness. The period of adaptation for the starter should end when the calf is eating at least 453g 
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of starter per day. It also is recommended to cut the milk feeding to about the half during the last 
week before early weaning. 
Early weaning is a technique used to improve cow body condition. During lactation, there 
is loss of body condition due to the increased nutrient requirements associated with lactation. By 
early weaning the cow’s nutrient requirements for lactation disappear, and cows are able to 
increase or maintain their body condition scores. Also early weaning (between 45 to 105 days) 
can improve conception rates because cows have a greater opportunity to rebreed in an optimum 
time frame. Moreover, early weaning improved forage availability for the cow because there is a 
reduction of the cow’s dry matter intake and also it eliminates the demand on the forage from the 
calf. Consequently, the cows remaining on the pasture have access to more forage and demands 
on the pasture are reduced, which can enhance sustainability and forage production in the future. 
By weaning early and providing a highly nutritious diet, calves can reach their genetic 
potential to marble and have increased quality grade at slaughter. One of the disadvantages of 
early weaning is that instead of their mother's milk and pasture, early weaned calves will eat high 
quality grains, protein supplements and/or commercially prepared feedstuffs, and consequently 
the calves requires greater attention to proper  nutrition and health. Furthermore, weaning calves 
earlier will result in increased expenses for the beef cattle producer.  
CREEP FEEDING 
Creep feeding is the managerial practice of providing concentrated-based supplemental 
feed to the nursing calf. Creep feeding maximizes the calf’s full growth potential, when the calf 
is not getting enough nutrients from the cow’s milk or because a lack of pasture due to drought. 
Feedstuffs are provided in a creep feeder or some type of physical barrier, which allows the calf, 
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but not the cow, to have access to the supplemental feed (Eversole 2009). Providing a creep 
ration to nursing calves grazing forage has been a management strategy to increase weaning 
weight (Martin et al. 1981). Multiple studies showed that the use of creep feeding produce higher 
weights at weaning (Faulkner et al. 1994; Lancaster et al. 2004; Tarr et al. 1994). However, 
statistical differences were not observed (P>0.10) in dry matter intake, average daily gain (ADG) 
or gain:feed (G:F) between calves that received creep feed or not (Faulkner et al. 1994). 
However, the creep-fed calves had a statistical advantage in quality grade by means of the 
marbling score (P<0.05), with no difference in yield grade, ribeye area, or backfat (Shike 2007; 
Tarr et al. 1994). 
MICROARRAYS AND BIOINFORMATICS TECHNOLOGY 
General Aspects of Microarray Construction and Use  
cDNA microarrays evolved from Southern blots, with clone libraries gridded out on 
nylon membrane filters being an important and still widely used intermediate (Claycomb and 
Orr-Weaver 2005). Use of this technique increased with the introduction of non-porous solid 
supports, such as glass allowing miniaturization and fluorescence based detection. The technique 
broadly known as microarray (Liang and Pardee 1992; Stein and Liang 2002) allows direct and 
simultaneous comparison of multiple samples, so that relative changes in gene expression 
between and within individuals can readily be identified. Microarray-based technologies for gene 
expression are widely popular in the scientific community and provide several advantages over 
other techniques (Schena et al. 1995). In particular, microarrays allow the global assessment of 
gene expression. It is therefore possible to asses not only the expression status of a particular 
gene, but also the expression pattern of that gene relative to others, which clearly represents an 
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useful approach for understanding polygenic regulation of a complex process such as muscle 
development. 
There are a variety of microarray platforms that have been developed as described in the 
review of (Cummings and Relman 2000). Basically a glass slide or membrane is spotted or 
arrayed with DNA fragments or oligonucleotides that represent specific coding regions of genes. 
Construction of microarrays is generally dependent on information gained from genome 
sequencing or EST (expressed sequence tag) projects that provide large sets of annotated clones 
and sequences (Rimm et al. 2001). The construction of cDNA microarray slides is based on 
fragments of candidate genes provided by the investigator. PCR products or oligonucleotides are 
directly spotted or printed onto glass slides to develop a microarray (Kauraniemi et al. 2001). 
Oligonucleotides can be designed and purchased from a number of commercial providers.   
Purified RNA is then fluorescently or radioactively labeled and hybridized to the 
slide/membrane. In some cases, hybridization is done simultaneously with “reference” RNA to 
facilitate comparison of data across multiple experiments. A reference RNA is basically made 
from a pool of RNA from different tissues or cell types.  Signal intensity data for each spot on a 
microarray is obtained by laser scanning or autoradiographic imaging. At this point, the data may 
then be entered into a database and analyzed.  
In fact, the most common design for competitively hybridized arrays is the reference 
design (Tempelman 2005). Each experimental sample is hybridized against a common reference 
sample. Although this effectively means that only one sample of interest is hybridized per chip, 
the reference design has several practical advantages over more efficient designs: it extends 
easily to other experiments, if the common reference is preserved; it is robust to multiple chip 
failures; and it reduces incidence of laboratory mistakes, because each sample is handled the 
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same way (Tempelman 2005). The reference sample is used in many chips, therefore the 
reference mRNA needs to be abundant. When comparing treatment versus control samples the 
most natural reference is the wild type or the biological controls, which are often the most 
abundant. However, if the study aims to compare each of several samples against all others, there 
is no natural control. A reliable alternative is a common reference obtained by pooling all 
samples (Cummings and Relman 2000). This enables samples to be compared with each other 
indirectly. A pooled reference sample reduces the number of extreme gene ratios (which have 
large errors) on each chip. Some labs take this further and create a universal reference: a pool of 
mRNA derived from several standard cell lines, which they use most often in their experiments. 
Using a universal reference enables them to compare results for all their experiments (Loor et al. 
2007). 
The Illinois 13,000 Oligonucleotide Microarray 
Previous work at the University of Illinois has explored and linked large-scale liver tissue 
gene expression data with metabolic data to study tissue function e.g.,(Loor et al. 2005; Loor et 
al. 2006; Loor et al. 2007).  In the most recent experiment, this group studied nutrition-induced 
ketosis and how it altered gene networks in the liver of periparturient dairy cows (Loor et al. 
2007).  This study used a 13,000 gene oligonucleotide microarray, which essentially represented 
an expansion of the 7,000 cDNA microarray platform developed originally (Everts et al. 2005).  
The main focus of that study was to test the hypothesis that metabolic and signaling gene 
networks are coordinately altered in liver during feed restriction and ketosis in periparturient 
cows.  Blood metabolite and liver composition data typical of periparturient dairy cows were 
observed, making this study a suitable model for periparturient dairy cows in commercial dairy 
herds (Loor et al. 2007). The findings, as a whole, revealed genes that could play key roles in 
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hepatic metabolic adaptations to negative energy balance. In addition, coupling metabolic and 
performance data with gene expression allowed development of an integrative model of liver 
function during ketosis. 
Details of the development of the 13,257 bovine oligonucleotide microarray used in one 
of the chapters of this thesis can be found in the Supplementary Materials and Methods from 
(Loor et al. 2007).  Briefly, an embryonic bovine cDNA library and 38,732 high-quality 
expressed sequence tag (EST) sequences based on the cattle 7,872 cDNA array [accession 
GPL2864, National Center for Biotechnology Information (NCBI)] (Everts et al. 2005) were 
filtered for repeats as well as sequences of viral, bacterial, or mitochondrial origin using 
RepeatMasker (Smit 1999).  Subsequently, seventy-base long (i.e., 70-mers) oligos from the 
unique cluster and singlet sequences were designed. Sequence alignments of designed oligos 
were done by BLASTN similarity searches against human RefSeq, mouse RefSeq, bovine 
RefSeq, human UniGene, mouse UniGene, bovine UniGene, bovine TIGR and the bovine 
genome using an E-value cut-off of E ≤ e-5 and scoring threshold of 40 bp as described by 
(Everts et al. 2005).  Best hits were used to annotate the cattle sequences.  NCBI UniGene and 
Gene databases were used for functional annotation (e.g., gene symbol, gene name, function, 
OMIM number, PubMed identification numbers) and Gene Ontology (GO) annotation (Everts et 
al. 2005). This microarray contains ca. 97% unique elements. 
In order to examine the functional coverage of the microarray, annotated sequences on 
the microarray were uploaded into Ingenuity Pathway Analysis® (IPA, www.ingenuity.com) 
(Loor et al. 2007).  This is a web-based software program used to assign genes to functions or 
pathways, and to map sets of genes together leading to complex networks.  The Ingenuity 
Knowledge Base (IKB) is manually curated using data from studies with mouse, rat, and human 
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cells and/or tissues that have been published in high-impact journals (e.g., Science, Nature, 
Proceedings of the National Academy of Sciences).  Livestock data are not currently part of the 
IKB but users can manually create relationships based on published data.   
Previous Microarray Analysis of Bovine Skeletal Muscle 
It is known that undernutrition can affect processes such as protein turnover and 
connective tissue remodeling, and can lead to muscle atrophy (Allingham et al. 1998). These 
processes and their regulation are of interest in the context of managing livestock for optimal 
production quality and efficiency.  Recent studies have utilized bovine cDNA microarrays to 
study skeletal muscle gene expression profiles during nutritional restriction. Using skeletal 
muscle tissue from Brahman steers during nutritional restriction (Byrne et al. 2005) identified 
156 differentially expressed array elements affected by weight loss induced through feed 
restriction. After sequence and annotation analyses, 57 upregulated elements represented 29 
unique genes, and 99 downregulated elements represented 28 unique genes. Most of these co-
regulated genes clustered into groups with distinct biological functions related primarily with 
protein turnover and cytoskeletal metabolism. (Wang et al. 2005) used a 9.6 K cattle muscle/fat 
cDNA microarray to evaluate transcript profiles of skeletal muscle tissue of Japanese Black and 
Holstein steers at 11 mo of age. Fifty-two elements representing 17 genes were identified as 
preferentially expressed in Longissimus muscle of Japanese Black, and 7 genes were found 
preferentially expressed in Holstein steers.  Genes expressed preferentially in Japanese Black 
muscle tissue included lipogenic transcription factors (sterol regulatory element binding factor 1, 
SREBF1; thyroid hormone responsive SPOT14, THRSP) as well as lipogenic enzymes (stearoyl-
CoA desaturase, SCD; fatty acid binding protein 4, FABP4).  Holstein skeletal muscle was 
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characterized by genes associated with energy metabolism (myosin genes; pyruvate 
dehydrogenase kinase 4, PDK4) and muscle contraction (ATPase, ATP2A1). 
(Lehnert et al. 2006) using cDNA microarrays generated gene expression profiles of beef 
cattle muscle from steers undergoing postweaning undernutrition. The most common pattern of 
gene expression change observed was a 2- to 5-fold downregulation of genes associated with 
muscle structural proteins (Actin, Myosin), metabolic enzymes (ATP1A2, creatine kinase, 
lipoprotein lipase, pyruvate kinase), extracellular matrix (collagens, fibronectin), and calcium 
signaling in the muscle of underfed animals compared with rapidly growing animals. After a 
period or re-alimentation, there was a return to mRNA expression levels similar to that of rapidly 
growing steers. This pattern was particularly evident in 36 genes related with skeletal muscle 
fibers, such as structural proteins (ACTA1, ACTG2, ACTN3, ASB12, MRCL3, ASB12 and 
MRCL13) and metabolic enzymes (ALDOA, ATP1A2, CKM, CKMT2, ENO3, GAPDH, LPL). 
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CHAPTER 2: BIOINFORMATICS ANALYSIS OF THE TRANSCRIPTOME  IN 
LONGISSIMUS MUSCLE OF EARLY-WEANED ANGUS STEERS FED DIFFERENT 
LEVELS OF STARCH DURING THE GROWING PHASE  
Transcriptional control of gene networks as a long-term mechanism affecting the level of 
expression of several key enzymes governs metabolic regulation in complex organisms. 
Objectives were to evaluate temporal gene expression profiles in Longissimus thoracis et 
lumborum (LTL) of early-weaned (155 ± 10 d age at weaning) Angus steers (n = 7/diet) fed 
a high-starch (HiS, NEG = 5.98 MJ/kg diet dry matter) or low-starch (LoS, NEG = 4.97 MJ/kg) 
diet for 120 d, at which point all steers were switched to a common feedlot diet until slaughter. 
LTL biopsies for transcript profiling and blood for metabolite analyses were collected at 0, 60, 
120, and 220 d of feeding. A 13,153 bovine oligonucleotide (70-mers) array was used for 
transcript profiling. Functional analysis was performed by means of KEGG and DAVID 
softwares. Analysis of variance using a cutoff of P value <0.05 and false discovery rate <0.01 
revealed ca. 5,600 differentially expressed genes (DEG) due to time alone. During the growing 
phase, the most striking differences occurred at 60 vs. 0 d when a total of 1,471 DEG were 
observed. The number of DEG due to time, however, was 3,702 at 220 vs. 0 d. Within the 1,934 
DEG, the functional analysis revealed >45 enriched canonical pathways (e.g., Pentose and 
glucuronate interconversions, Sulfur metabolism, Steroid biosynthesis, Cytochrome P450 
biosynthesis, Ascorbate and Aldarate metabolism, Fatty Acid Metabolism and PPAR signaling). 
The results for the DAVID analysis showed that the highest impacted lipid-related biological 
process was the low-density lipoprotein particle clearance which had a inhibited total direction. 
The results for the DAVID gene expression-related biological processes analysis showed that the 
highest impacted biological process was the circadian regulation of gene expression which 
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presented an activated total direction, which had the strongest activation level of the whole 
significant terms at the time comparison 220 vs. 0, due to the high activation presented during 
the finishing phase. Results revealed marked adaptations in networks and pathways during rapid 
growth of skeletal muscle. 
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INTRODUCTION 
Metabolic regulation in complex organisms relies partly on transcriptional control of 
gene networks as a long-term mechanism affecting the level of expression of several key 
enzymes (Desvergne et al. 2006). In this study we present a comprehensive analysis of canonical 
pathways and biological functions of microarray data from Longissimus muscle using a novel 
bioinformatics functional analysis to uncover potential novel mechanisms associated with muscle 
growth and adipocyte differentiation. 
A recently-developed bioinformatics tool so called Dynamic Impact Approach (DIA) was 
used for computational analysis of the microarray data using information from freely-available 
databases (Bionaz M. 2011). The Kyoto Encyclopedia of Genes and Genomes (KEGG) database 
was used to determine the most impacted canonical pathways, and the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) database was used to determine the most 
relevant subcategories within the 3 gene ontology domains (cellular component, molecular 
function and biological processes), focusing primarily on lipid- and gene expression-related 
biological processes. 
The specific objectives of the present study were to (1) determine the most impacted 
metabolic pathways during the growing and finishing period in Angus steers; (2) establish the 
pathways that are most impacted at a greater  frequency and, which pathways have a specific 
impact during the life of the steers; and (3) distinguish which are the biological processes that 
govern the development of skeletal muscle and intramuscular fat in these animals. 
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MATERIALS AND METHODS 
Experimental Animals, Diets and Sampling 
Complete details of the experimental procedure have been reported previously 
(Graugnard et al. 2010). Briefly, fourteen purebred Angus steer calves from the University of 
Illinois beef cattle herd were utilized (7 animals per treatment) to examine the effects of two 
different levels of starch in the diet. Early weaning was performed at 155 ± 10 d after birth. The 
steers were randomly assigned to a high-starch (HiS; 5980 kJ/kg diet DM) or a low-starch (LoS; 
4970 kJ/kg diet DM) diet for 112 d. Dietary treatments in the present study were specifically 
designed to provide contrasting levels of starch and fiber while providing sufficient energy, i.e. 
calculated net energy for gain in diets HiS and LoS differed by about 20% but was adequate in 
both cases to support > 1.5 kg body weight per day. Both diets were formulated to be 
isonitrogenous. The LoS–high fiber diet contained (g/kg DM): 350 maize silage; 200 maize 
gluten feed; 380 soya hulls; 30 cracked maize; 30 soybean meal (490 g/kg crude protein). The 
HiS–low fiber diet contained (g/kg DM): 200 maize silage; 680 cracked maize; 110 soybean 
meal (490 g/kg crude protein). Both diets contained 10 limestone/dicalcium 
phosphate/mineral/vitamin/urea/dry molasses mixture (g/kg DM). Calculated dietary fiber 
content was 5.9% with HiS and 24% with LoS. At the end of the growing phase, steers on each 
group were gradually adapted to a common high-grain finishing diet containing 6030 kJ 
calculated net energy for gain per kg DM. All steers received an implant of 20 mg oestradiol 
benzoate and 200 mg progesterone (Component E-S; Vetlife Inc., West Des Moines, IA, USA) 
after the biopsy on day 60. Muscle biopsies were collected at 0, 60, 120 and 220 days relative to 
the start of feeding treatment diets (i.e. a range 
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biopsy sample collection, RNA extraction and microarray analysis was widely covered 
previously (Graugnard 2011; Graugnard et al. 2009).  
Data from the microarray analysis were normalized for dye and microarray effects (i.e., 
Lowess normalization and array centering) and used for statistical analysis. Data were analyzed 
using the Proc MIXED procedure of SAS (SAS, SAS Inst. Inc., Cary, NC). Fixed effects were 
diet (HiS, LoS), day (0, 60, 120, 220), and dye (Cy3, Cy5). Random effects included steer and 
microarray. Raw P values were adjusted using Benjamini and Hochberg’s false discovery rate 
(FDR)(Reiner et al. 2003). Differences in relative expression due to diet or treatment were 
considered significant at an FDR-adjusted P =0.35. 
Bioinformatics analysis of microarray data was performed using DIA (Loor et al. 2011) 
and information from the freely-available online databases (Bionaz M. 2011) Kyoto 
Encyclopedia of Genes and Genomes (KEGG) and Database for Annotation, Visualization, and 
Integrated Discovery (DAVID) v6.7 databases. KEGG GENES is a source of information about 
all the genes of genomes that have been completely or partially sequenced(Kanehisa 2011). 
DAVID is a web-based functional annotation tool and the latest version (DAVID v6.7) contains 
information on more than 1.5 million genes from over 65,000 species. A list of protein or gene 
identifiers was uploaded all at once to extract and summarize functional annotations associated 
with group of genes or with each individual gene. An explanation of the DIA analysis has been 
reported previously (Loor et al. 2011). 
RESULTS 
The total number of differentially expressed genes (DEG) due to time is presented in 
Figure 1. The highest number of DEG, 1,924 downregulated and 2,108 upregulated (P value < 
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0.05; FDR < 0.01), was observed at 220 vs. 0 . The lowest number of DEG was observed at 120 
vs. 60, with 743 downregulated genes and 690 upregulated genes (P value < 0.05; FDR < 0.01). 
Pathway Analysis 
Overall KEGG Results  
The KEGG category “Metabolism” and its subcategories were the most relevant for all 
time comparisons in this dataset due to the higher impact. When the time comparison 
representing the cumulative effect of the whole experiment (220 vs. 0) was analyzed the most 
impacted metabolic pathways were “Biosynthesis of unsaturated fatty acids” and “Steroid 
biosynthesis” under the subcategory “Lipid Metabolism”. “Phenylalanine, tyrosine and 
tryptophan biosynthesis” under the subcategory “Amino Acid Metabolism” had also a high 
impacted activation. 
When only the growing phase was considered (120 vs. 60 and 60 vs. 0), “ Ascorbate and 
aldarate metabolism” (“Carbohydrate Metabolism” subcategory), “Drug metabolism - 
cytochrome P450” (“Xenobiotics Biodegradation and Metabolism” subcategory) and “Retinol 
metabolism” (“Metabolism of Cofactors and Vitamins” subcategory) were the most impacted 
and inhibited. When only finishing phase was considered (220 vs. 120), 
“Glycosylphosphatidylinositol(GPI)-anchor biosynthesis” (“Glycan Biosynthesis and 
Metabolism” subcategory), “Pentose and glucuronate interconversions” (“Carbohydrate 
Metabolism” subcategory) and “Sulfur metabolism” (“Energy Metabolism” subcategory) in that 
order, were the most impacted metabolic pathways, having inhibition and activation respectively 
(Table 1a). 
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The highest-impact subcategory within “Genetic Information Processing” was 
“Transcription”, and was activated. In contrast, “Replication and Repair” was highly impacted 
but was inhibited during the finishing phase. Within the “Environmental Information Processing” 
category, the subcategories “Signal Transduction” and “Membrane transport” had the highest 
impact and were inhibited during the finishing phase. The inhibited “Cell communication” and 
the activated “Cell motility”, were the most impacted “Cellular Processes” categories, especially 
during the finishing phase (Table 1). 
Within the “Organismal Systems” category, “Sensory system” and “Development” were 
the most impacted. In particular, “Development”, had a relatively low inhibition at the beginning 
of the growing phase (60 vs. 0), a slight activation at the end of the growing phase and beginning 
of the finishing phase (120 vs. 60), and a strong inhibition during the finishing phase (220 vs. 
120). Within the “Human Diseases” category, “Cancer” and “Cardiovascular Diseases” 
subcategory were the most impacted with inhibition and activation respectively (Table 1). 
Most Recurrent Pathways 
The most-recurrent pathways according with a cutoff of 50% of the maximum total 
impact value of the whole KEGG analysis output is shown in Table 2. “Pentose and glucuronate 
interconversions” and “Sulfur Metabolism” pathway were the most recurrent pathways in the 
dataset, i.e. they appeared as significant in the 4 time comparisons analyzed. During the finishing 
vs. growing phase, “Pentose and glucuronate interconversions” had a higher impact and was 
markedly inhibited compared to “Sulfur Metabolism” which was activated. 
Also recurrent in the analysis, and with higher impact at 220 vs. 0 d, were “Steroid 
biosynthesis”, “Drug metabolism - cytochrome P450”, “PPAR signaling pathway”, “Ascorbate 
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and aldarate metabolism” and “Fatty acid metabolism”. The first two pathways were overall 
inhibited and the last three were activated. The “PPAR signaling pathway” had an inhibition 
during the growing phase (60 vs. 0) and a relatively high activation during the beginning of the 
finishing phase (120vs.60) (Table 2).  
The least-recurrent pathways are presented in Table 3. Among those, the most impacted 
one and strongly–inhibited was “Glycosylphosphatidylinositol (GPI) - anchor biosynthesis” 
(“Glycan Biosynthesis and Metabolism” subcategory) and the slightly activated “Biosynthesis of 
unsaturated fatty acids”. Moreover, the degree of the impact of these two pathways was the 
highest compared with all the other pathways analyzed. 
Biological Processes 
The DAVID output of biological processes (BP) analysis revealed 2,300 significant (P 
value < 0.05; FDR < 0.01) categories Considering the total impact and total flux, which is based 
on the overall outcome considering all time comparison for each pathway, an exhaustive 
selection among the 2,300 biological processes was performed to uncover those related with lipid 
metabolism and gene expression. Results of this selection revealed that 100 lipid-related 
biological processes and 141 gene expression-related biological processes. From these a cutoff 
was applied considering as significant all the biological processes that had a total impact value 
equal to or greater than 50% of the maximum total impact for the whole DAVID biological 
processes analysis. The results for the lipid-related biological processes are shown in 
Supplemental Table 5, where the black continuous line depicts the cutoff applied.  
The results of the DAVID lipid-related biological processes analysis underscored that 
“lipoprotein metabolism” was the most affected in terms of the trafficking of LDL and HDL. 
During the first-half of the growing phase (60 vs. 0), there was a strong inhibition of “LDL 
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particle clearance”. During the second half of the growing phase and the first portion of the 
finishing phase (120 vs. 60), there was a switch in this pattern with an intense LDL particle 
clearance and an inhibition of “LDL receptor catabolic processes”. Despite having activation 
during the beginning of the growing phase (60 vs. 0), the positive regulation of LDL receptor 
catabolic process was overall inhibited (Table 4). From the middle to the last point of the 
finishing phase (220 vs. 120) the inhibition of “LDL clearance” was reestablished (Table 4). Low 
density lipoproteins receptors (LDLR) have inhibition of the positive regulation of its catabolic 
processes. Moreover, high density lipoproteins (HDL), LDL, and remnant chilomycron presented 
an inhibition of its clearance during all time comparisons (Table 4). Although, removal of LDL 
and HDL was activated during the finishing of the growing phase and the beginning of the 
finishing phase (120 vs. 60) (Table 4).  
The “biosynthetic process of acylglycerol” was also highly impacted with inhibition at 
the beginning of the growing phase (Table 4). The “differentiation of white adipose cells” had 
the highest level of activation at 220 vs. 0. This strong activation was more noticeable during the 
second portion of the finishing phase (220 vs. 120) (Table 4). Finally, “DAG metabolic process” 
had an activated total flux but it was inhibited during the growing phase (60 vs. 0) (Table 4). 
The process of “formation of steroids” was inhibited during the growing phase and 
activated 120 days after early weaning. Also, the sterol trafficking into, out of or within or 
between cells was activated only at 120 vs. 60 days after early weaning. (Table 4).The regulation 
of sterol transport was mainly inhibited but it had a slight degree of activation during the end of 
the growing phase and the beginning of the finishing phase (120 vs. 60) (Table 4).  
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There was an inhibition of the “negative regulation of lipid transport” in the times when 
“acyl carnitine transport” was activated (60 vs. 0, 220 vs. 0, 220 vs. 120) (Table 4). There was an 
overall inhibition of “positive regulation of the fatty acid metabolic processes” during the time 
points studied, i.e. this process was only activated at 120 vs. 60 d. This biological process 
strongly inhibited during the growing phase (60 vs. 0) and during the finishing phase (220 vs. 
120) and was activated between the second half of the growing phase (120 vs. 60 d).  
The results for gene expression-related biological processes by DAVID analysis are 
shown in Table 4 and Supplemental table 6, where the black continuous line denotes the cutoff 
applied. Results showed that the most-impacted biological process was the “circadian regulation 
of gene expression” which was overall activated due to a strong response during the finishing 
phase(Table 4). Within “circadian regulation of gene expression” there was evidence that genes 
that are involved in the regulation of feed intake and satiety were the most affected during the 
finishing phase (data not shown).  
The second most impacted gene expression-related biological process was the activated 
“positive regulation of transcriptional preinitiation complex assembly”, even though it had the 
highest inhibition among all the significant terms during the beginning of the growing phase (60 
vs. 0). switching this feature to a strong activation during the second-half of the growing phase 
(120 vs. 60) (Table 4). The total flux for “negative regulation of nucleotide metabolic process” 
was activated due to the response beginning at 120 days after early weaning (Table 4). Lastly, 
the “ribosome and ribosomal small subunit export from nucleus” was overall activated, same us 
the “establishment of the ribosome localization”. Both terms were inhibited during the growing 
phase and activated during the finishing phase (Table 4). 
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DISCUSSION 
Pathway Analysis  
 Ascorbate (Glutathione dehydrogenase) is a water-soluble antioxidant that acts as cofactor in the 
carnitine biosynthetic pathway in liver and kidney(Rebouche 1991) and to some extent in 
skeletal muscle(Savini et al. 2005; Vaz and Wanders 2002). Carnitine is required to transfer the 
fatty acid moiety through the mitochondrial membrane, hence, Ascorbate has an indirect control 
on fatty acid oxidation. Ascorbate also facilitates glycogen storage in skeletal muscle and delays 
the negative effect of oxidative stress on collagen remodelling by increasing the degradation of 
collagen by matrix metalloproteinases (MMPs), which will decrease the collagen solubility, 
improving meat tenderness(Archile-Contreras et al. 2011; Purslow et al. 2011). 
Cytochrome P450 proteins mediate NADPH-dependent electron transport and function to 
oxidize a variety of structurally unrelated compounds, including steroids, fatty acids and 
xenobiotics (Barbosa-Sicard et al. 2005). During the production cycle, livestock animals are 
exposed to a wide range of xenobiotic agents (i.e., feed additives), the great majority of which 
are metabolized by different enzyme systems usually yielding less lipophilic, more polar and 
hence less active metabolites readily eliminated from the body via normal excretion routes 
(Virkel et al. 2009). Some of these lipophilic environmental pollutants tend to escape from the 
organ’s detoxification system and are accumulated in the adipose tissue leading to an 
interference in the gene expression profile of the tissue (Yoshinari et al. 2004). Also, in this 
pathway there were signs of lipid protection mechanisms against oxidation via Glutathione –S – 
transferases (Williamson 1988) and against arachidonic acid oxidation via cytochromes 
(CYP1A2 and CYP2E1) (Rifkind 1995). The potential accumulation of lipophilic compounds in 
WAT could have been associated with the activation of the transcription factors (i.e. Nrf2) that 
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increase the capacity of detoxification in this tissue by means of aryl hydrocarbon receptors 
(Yoshinari et al. 2006). 
 The marked inhibition of cytochrome P450 enzymes, which play a role in the production 
of all-trans retinoic acid, likely was responsible for the overall inhibition of Retinol Metabolism 
during the growing phase. These three inhibited metabolic pathways with high impact during the 
growing phase are interrelated because the xenobiotic oxidation that is catalyzed by particular 
forms of cytochromes P450 are inhibited by arachidonic acid and retinoic acid (Yamazaki and 
Shimada 1999). 
 The inhibition of “Glycosylphosphatidylinositol (GPI) - anchor biosynthesis” pathway 
during  the finishing phase could have been a result of the suppression of a 
glycosylphosphatidylinositol specific phospholipase that blocked the cAMP-to-adenosine 
conversion associated with lipid droplet and inhibition of lipolysis (Muller et al. 2008). 
 Glucuronate is a highly polar molecule which is incorporated into proteoglycans that 
occur in the connective tissue as well as combining with steroid hormones. The uronic acid 
pathway is utilized to synthesize UDP-glucuronate, glucuronate and L-ascorbate. The pathway 
involves the oxidation of glucosae-6-phosphate to UDP-glucuronate. The uronic acid pathway is 
an alternative pathway for the oxidation of glucose uncoupled from energy production, but is 
utilized for the generation of the activated form of glucuronate, UDP-glucuronate (King 2011a). 
“Pentose and glucuronate interconvertions” pathway was inhibited during the finishing phase 
meaning that the conversion of proteoglycans in the connective tissue was down regulated 
making to this pathway be switched to the conversion of glycogen (Lieberman 2009). 
 The metabolism of sulfur is an important process in the production of a number of vital organic 
molecules such as cysteine, methionine, coenzyme A, and iron-sulfur clusters. The importance of 
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sulfur laid down on the sulfhydryl (thiol) functional group. Thiol-based reactions have diverse 
biological functions, i.e. thiols in thioredoxins provide reductive power for the synthesis of 
biological molecules; thiols in coenzyme A facilitate the oxidation of pyruvate and fatty acids to 
generate energy for skeletal muscle growth and intramuscular fat accumulation (Senaratne 2009). 
Biological Processes 
 
 The inhibition of the LDL particle clearance which occur via receptor-mediated 
endocytosis(King 2011b), could be partly explained by the activation of the positive regulation 
of the LDL receptor catabolic process. Such response would result in the breakdown of LDL 
particle receptors and lead to reduced LDL receptor number in myocytes and adipocytes. 
Deficiency of the LDLR results in abnormal elevation of cholesterol within the intermediate and 
low density plasma lipoproteins (IDL/LDL) (Stein et al. 2000) that could lead to a change in 
fiber type proportion in skeletal muscle of steers (Tikkanen et al. 1996). 
 The lack of LDLR expression in this study, in all the time comparisons, probably was 
associated with the inhibition of chylomicron remnant particle removal from the circulation. 
Apolipoprotein E is associated with LDLR, and serves as a marker that helps recognize these 
particles by LDLR (Mahley et al. 1989). The results suggest that at the time of treatment diets 
administration, the mechanism of production of LDLR might not be efficient enough to capture 
the high content of lipoproteins present in the circulation, thereby producing the blocking of it. 
Moreover, the process of endocytosis of GPI-anchored proteins via Clathrin-coated vesicles of 
LDLR complexes present in adiposomes, were affected in these animals. LDL particle clearance 
was inhibited due to a GPI-anchored proteins biosynthesis inhibition (Table 4).  
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The temporal increase in activation of the highly impacted differentiation of white fat 
cells and biosynthesis of acylglycerols was expected based on previous results(Smith et al. 1998; 
Tokach 2010). In fact, our results confirm that intramuscular fat deposition in LTL increased 
progressively over time (Okumura et al. 2007). In addition, to adipocyte development the 
apparent increase in steroidogenesis that was observed might have been a response to increase 
transport of newly-synthesized cholesterol from the adipose tissue to the circulation (Feingold et 
al. 1985). The inhibition of mitochondrial β-oxidation likely as a result of lower acyl carnitine 
transport (Bartlett and Eaton 2004) during the same time-frame also supports the preferential 
channeling of long-chain fatty acids towards acylglycerol formation and adipocyte 
differentiation, i.e. adipogenesis. 
In conclusion, each of these lipid-related biological processes underscored that during the 
growing phase there is a reduction in intracellular lipid transport and energy expenditure due 
partly to the lack of LDL receptors (Hofmann et al. 2007). The inhibition of the carnitine shuttle 
and the activation of biosynthesis of acylglycerols also are signs that esterification was a 
predominant process during the finishing phase. 
Circadian regulation of gene expression is related to any process that modulates the 
frequency, rate or extent of gene expression pattern that persists within a period of approximately 
24 hours (Thornton 2011a). For this biological process, in the time comparison 220 vs. 0, there 
was an activation of a dopamine receptor (DRD2). The activity of this receptor is mediated by G 
proteins which inhibit adenylyl cyclase (Vortherms et al. 2006). 
This PIC complex exerts a role in adipogenesis via their interaction with vitamin D 
receptor (VDR) (Zawel and Reinberg 1995). Thus, the results suggest that this complex has a 
minor role in regulating gene transcription during the first-half of the growing phase, i.e. it may 
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be more relevant as the animal reaches certain stage of maturity. Transcription initiation of genes 
encoding mRNAs is produced by RNA polymerase II (pol ll) and a group of general initiation 
factors which are present in this PIC complex (Sawadogo and Sentenac 1990). 
Negative regulation of nucleotide metabolic processes is related to any process that stops, 
prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways 
involving nucleotides (Thornton 2011b). This biological process is related to the production of 
cAMP from ATP as an example. The fact that this process was activated during the finishing 
phase suggests that adenylate cyclase activity might have been reduced leading to an overall 
inhibition of lipolysis (Londos et al. 1985), and supports the observation of a robust adipogenic 
process over time. 
Ribosomes are divided into two subunits. The smaller subunit binds to the mRNA, while 
the larger subunit binds to the tRNA and the amino acids (Benne and Sloof 1987). Ribosomal 
small subunit export from nucleus and the directed movement of the ribosome to a specific 
location was also activated during the finishing phase, meaning that transcription process have 
been occurring during this last stage. 
GPI-anchored proteins create a channel in the intraluminal vesicules present in the lipid 
droplets that serves as a binding site for LPL, creating a platform for lipolysis (Muller et al. 
2011). The circadian regulation of gene expression was activated (Table 4) due to an activation 
of the Dopamine receptor activity (data not shown) that activates adenylate cyclase via coupling 
to Gi/Go, increasing cAMP which activates protein kinase A (PKA). PKA subsequently 
phosphorylates and activates hormone sensitive lipase (HSL) which hydrolyzes stored 
triglyceride to fatty acids and glycerol. As a whole, the adaptations that were observed in these 
processes suggest that lipoprotein removal (i.e. TG hydrolysis) from the vascular adipose tissue 
50 
 
is a dynamic process that seems closely associated with the needs of skeletal muscle and 
intramuscular fat for fatty acids. 
 
SUMMARY AND CONCLUSIONS 
 
“Pentose and glucuronate interconversions”, “Sulfur Metabolism”, “Steroid 
biosynthesis”, “Ascorbate and aldarate metabolism”, “Cytochrome P450 metabolism”, “PPAR 
Signaling Pathway” and “Fatty acids metabolism” were the most recurrent KEGG significant 
pathways during the growing and finishing phase. KEGG pathway results seemed to be in 
accordance with the metabolic processes that were expected. 
DAVID significant lipid-related biological processes revealed that the lack of LDL 
receptor might have curtailed lipogenesis during the growing phase. Activation of the carnitine 
shuttle and the biosynthesis of acylglycerols also are signals for lipolysis and lipogenesis during 
the finishing phase. DAVID gene expression-related most impacted biological process was the 
circadian regulation of gene expression due to dopamine receptors activation.  
In conclusion, this bioinformatics analysis uncovered unique biological processes and 
metabolic pathways some of which are associated with lipid droplets present in the white fat 
cells. This provides evidence of a role of the lipid droplet membrane in the trafficking of 
lipoproteins potentially dependent on the presence of GPI-anchor proteins, LDL receptors and a 
specific concentration of LDL to ensure a steady stream of lipoproteins inside the adipocytes. 
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Time Comparison 
0 vs 60 60 vs 120 120 vs 220 220 vs 0
# 
D
EG
0
1000
2000
3000
4000 #DEG up 
#DEG down
21081985
690977
1924
1799
743
957
Figures and Tables 
Figure 1. Raw P value, False Discovery Rate (FDR) and number of differentially expressed 
genes due to diet effect, time effect and time x diet interaction. Total Number of Differentially 
Expressed Genes due to Time on Experiment for each time comparison. Total number of 
molecules = 13,153 (P value < 0.05; FDR < 0.01) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Effect Raw P FDR # Genes 
Diet 0.01 0.4-0.9 123 
Time x Diet 0.01 ≤0.30 522 
Time ≤0.02 ≤0.05 5,616 
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Table 1. Results of flux and impact uncovered by the Dynamic Impact Approach (DIA) based on 
Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways database analysis of the bovine 
muscle transcriptome for each time comparison. Flux represent the direction of each category 
and the corresponding subcategory (green color=inhibition, yellow color=stable, red 
color=activation with different color intensities according with the level of up-regulation or 
down-regulation). Blue lines show the impact of each category and the corresponding 
subcategories (P value < 0.05; FDR < 0.01). 
 
 
Flux Impact Flux Impact Flux Impact Flux Impact
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
6. Human Diseases
6.1 Cancers
6.2 Immune System Diseases
6.3 Neurodegenerative Diseases
6.4 Cardiovascular Diseases
6.5 Metabolic Diseases
6.6 Infectious Diseases
Category
60vs0 120vs60 220vs120 220vs0
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CHAPTER 3: NUTRITIONAL MANAGEMENT AFFECTS YIN YANG 1 AND 
ADIPOGENIC GENE NETWORK EXPRESSION IN LONGISSIMUS MUSCLE OF 
ANGUS STEERS 
Metabolic regulation in complex organisms relies partly on transcriptional control of 
gene networks as a long-term mechanism affecting the level of expression of several key 
enzymes. A transcription regulators analysis were performed from the results of a microarray 
study of beef cattle skeletal muscle samples, where it was compared the effects on 
myogenesis and adipocyte differentiation of early weaning with program fed high-
concentrate diet (EWS) (140 ± 6 days after birth) compared to steers that were normal 
weaned (218 ± 6 days after birth) with corn-based creep supplement (NWS), and normal 
weaning with no creep feeding (NWN). As a result, Yin Yang 1 was the transcription 
regulator which affects a greater number of molecules (126 genes). Within these affected 
genes, Insulin Growth Factor Binding Protein 5 (IGFBP5), Signal transducer and activator of 
transcription 5B (STAT5B), General Transcription Factor 2B (GTF2B), and K(lysine) 
acetyltransferase 2B (KAT2B), were the genes which showed to have a role on myogenesis 
and adipocyte differentiation. The outcome of this study was that the administration of starch 
in the diet of early weaned steers early in life, was expressed in higher scores for marbling 
deposition compared with normal weaned steers. There was an indirect effect of YY1 as a 
regulator of adipocyte differentiation, by means of the YY1 target genes. IGFBP5 which is 
both, PPAR and VDR target gene was the more clear enhancer of adipocyte differentiation. 
This was noticeable in early weaned steers by IGFBP5 expression that enhanced the release 
of IGF-1 which stimulates adipocyte differentiation. 
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INTRODUCTION 
 
Yin Yang 1 (YY1) is a ubiquitously-expressed 68 kDa DNA-binding zinc-finger 
transcription factor implicated in the regulation of genes that are important for cell growth, 
development, differentiation, cell cycle and programmed cell death (apoptosis) (Shi et al. 
1997). In non-ruminant skeletal muscle, the down-regulation of YY1 protein is central in the 
process of myogenesis because it relieves repression on the α-actin gene (ACTA1), an 
essential component of sarcomeres (Au 2004). Expression of YY1 in bovine tissue appears to 
be greater in fat cells of developing tissue as demonstrated by data from mammary fat pad vs. 
epithelium (Piantoni et al. 2010). Because the differentiation of 3T3-L1 preadipocytes to 
adipocytes is dependent on the suppression of the expression of CHOP-10 (a member of the 
C/EBP family) by YY1(Huang et al. 2008), this transcription factor also could play a role in 
intramuscular fat (IMF) deposition of beef cattle.  
Adipogenesis in non-ruminants is closely regulated through the formation of 
peroxisome proliferator-activated receptor gamma (PPARG)-retinoid X receptor (RXR) 
heterodimers leading to upregulation of expression of target genes (Garcia-Rojas et al. 2010). 
As such, the concentration of retinoic acid receptor (RAR) and RXR protein in the cell 
(hence, the formation of the heterodimers between these different nuclear receptors) regulates 
the effect of retinoids (metabolites of vitamin A) on adipogenesis (Villarroya et al. 1999). In 
bovine subcutaneous preadipocyte cultures both 9-cis and all-trans retinoic acid (RA) led to 
greater PPARG mRNA expression (Garcia-Rojas et al. 2010) mediated through the balance 
between amounts of RA isomers (α and β) and RAR and RXR receptor availability (Garcia-
Rojas et al. 2010). Restricting dietary vitamin A supplementation in growing steers did not 
affect skeletal muscle IMF cellularity but in the long-term led to greater percentage of IMF 
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compared with controls (Gorocica-Buenfil et al. 2007) suggesting potential roles of RA on 
lipogenesis rather than adipogenesis. 
In non-ruminant cells it has been shown that there is competition between RA and 
vitamin D3 for binding to RXR, which essentially diminishes the C/EBPβ-dependent 
activation of expression of PPARG and C/EBPα leading to an inhibition of adipocyte 
differentiation (Clarke et al. 1997). Similar to RXR, vitamin D Receptor (VDR) is a ligand-
dependent nuclear transcription factor that regulates the effects of vitamin D3 on several 
processes including adipogenesis and myogenesis via the initial formation of a nuclear 
VDR/RXR heterodimer (Raval-Pandya et al. 2001) in adipocytes (Kawada et al. 1996) and in 
myocytes (Chen et al. 1999). Although there is no direct link between YY1 and RXR, it is 
known that over-expression of YY1 in non-ruminant cells decreases vitamin D-dependent 
expression of target genes (Guo et al. 1997).  
In non-ruminants, the effects of intracellular RA and 1,25-dihydroxyvitamin D3 are 
lost when the cell reaches a stage of irreversible commitment to adipocyte differentiation 
driven by PPARG and C/EBPα, i.e. low levels (<10 nM) of RA and 1,25-dihydroxyvitamin 
D3 “indirectly stimulate” the development of adipose tissue (Kawada et al. 1996). From a 
developmental standpoint, it has been well-established that the capacity for IMF development 
in skeletal muscle of beef cattle is highest at an early age (Bonnet 2010; Smith 2009). We 
have previously determine that adipogenic gene networks in skeletal muscle are upregulated 
to a greater extent in animals fed high dietary starch during the growing phase (Graugnard et 
al. 2010). However, the expression patterns of RXR- and VDR-associated gene networks 
have not been evaluated. 
Recent transcriptomics and bioinformatics work in our group revealed that, among 36 
transcription regulators differentially-expressed during growth in Longissimus thoracis et 
lumborum (LTL) of early-weaned Angus steers, YY1 had the most relationships with other 
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differentially expressed genes  (total of 5,616) (Graugnard et al. 2010). Evaluation of the 
currently-known relationships between YY1 and other genes using Ingenuity Pathway 
Analysis (IPA) also indicated that it could interact with insulin-like growth factor binding 
protein 5 (IGFBP5), signal transducer and activator of transcription 5B (STAT5B), general 
transcription factor 2B (GTF2B), and K(lysine) acetyltransferase 2B (KAT2B). As such, 
YY1, as in bovine mammary fat pad (Piantoni et al. 2010) and non-ruminant models, could 
play a role in adipocyte differentiation and myogenesis in skeletal muscle of growing beef 
animals.  
The general hypothesis of the present study was that longitudinal expression of YY1, 
its closely-related targets, key receptors associated with vitamin-driven regulation of 
adipogenesis, and PPARG would be altered by nutritional management in LL of growing 
steers. As an initial step in establishing a role for YY1 in LL, the specific objective was to 
profile LL tissue from steers managed to consume different levels of dietary energy at an 
earlier or normal weaning age. Those data were combined with measures of growth 
performance and intramuscular fat deposition. 
 
MATERIALS AND METHODS 
Experimental Animals, Diets and Sampling 
All experimental procedures involving steers were approved by the University of 
Illinois Institutional Animal Care and Use Committee under protocol no. 09143. Angus steer 
calves from the University of Illinois beef cattle herd were utilized. Prior to the start of the 
study, steers were randomly assigned to early weaning (140 ± 6 days of age)plus a high-
starch diet (EWS), normal weaning (218 ± 6 days of age) plus corn-based creep supplement 
(NWS), and normal weaning with no creep feeding (NWN). The latter reflects closely the 
current trends in management in the US industry. Steers in NWS had access to creep feeders 
66 
 
in the pasture at time of early weaning. The EWS steers were fed to gain the same as steers 
on NWS. Table 5 shows the composition of the diet and creep supplement. The vitamin 
fraction of the dietary supplement contained 680,329 IU vitamin A /kg of; 68,039 IU vitamin 
D3/kg of, and 9,072 IU vitamin E /kg of. 
For the ~100 d treatment period (i.e. growing phase) EWS calves remained in the 
feedlot and NWS and NWN calves nursed their dams and grazed mixed pastures of 
endophyte-infected tall fescue (Festuca arundinacea), orchardgrass (Dactylis glomerata), 
bluegrass (Poa pratensis), red clover (Trifolium pratense), white clover (Trifolium repens) 
and alfalfa (Medicago sativa). Calves in NWS and NWN were weaned at 218 days of age and 
joined the early-weaned calves at the feedlot at which point both groups were fed a common 
finishing diet until slaughter (Table 5). Longissimus thoracis et lumborum (LTL; n = 8 per 
treatment) muscle biopsies were collected via biopsy from the same steers at 0 (early 
weaning), 96 (normal weaning), and 240 days after early weaning for transcript profiling 
using quantitative RT-PCR. 
Yin Yang 1 Gene Network Expression 
An exhaustive investigation using the 126 genes linked to YY1 in LL from our 
previous microarray study was conducted (Moisa et al. 2010) to assess which of these genes 
could be related to a biological process associated with myogenesis and adipogenesis. 
Interferon γ was one of the genes selected as part of the YY1 network (Ye et al. 1996) for its 
antagonistic role in adipogenesis by inhibiting PPARG (McGillicuddy et al. 2009); however, 
expression of this gene was undetectable even in cDNA  from the steer with the highest IMF 
content. The relative level of expression of YY1 and its target genes in adipose tissue was the 
first parameter that we had to corroborate during the literature search; once the expression 
level of a gene and, the possible role in adipose tissue was confirmed it was chosen for qPCR 
in LTL. The selection based on literature searches resulted in the identification of IGFBP5, 
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STAT5B, GTF2B, and KAT2B. These 4 genes act as links between YY1 and RXR β (RXRB), 
PPARG, and VDR.  
Biopsy Procedure, RNA Extraction, PCR, and Primer Design and Evaluation 
Details of all these procedures have been reported previously (Graugnard et al. 2010). 
Briefly, a needle biopsy gun was used to harvest ~0.5 g of tissue (12 gauge core biopsy 
needle; Bard Magnum, C. R. Bard, Covington, GA, USA). Extraction of RNA was exactly as 
reported previously using Trizol reagent. qPCR data were calculated with the 7900 HT 
Sequence Detection Systems Software (version 2.2.1, Applied Biosystems, CA). The final 
data were normalized using the geometric mean of the genes UXT, MTG1 and RPS15A, 
which were previously identified as suitable internal control genes in LL (Graugnard et al. 
2009). 
Primer Design and Evaluation and Network Analysis  
These procedures have been published previously (Graugnard et al. 2009). Only those 
primers that did not present primer-dimer, a single band at the expected size in the gel, and 
had the right amplification product (verified by sequencing) were used for qPCR. The 
accuracy of a primer pair also was evaluated by the presence of a unique peak during the 
dissociation step at the end of qPCR. 
 
Animal Performance, Ultrasound Data and Carcass Quality Analysis 
At the biopsy day, steers were weighted and the average daily gain (ADG) was 
calculated from the difference in body weight between time points. Steers had an individual 
electronic identification ear tag and individual feed intake data only for the finishing phase 
(i.e. after 96 d) were collected using the GrowSafe system (GrowSafe Systems Ltd, Alberta, 
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Canada). Individual animal ADG and daily dry matter intake (DMI) were used to estimate 
feed conversion efficiency (gain:feed, kg/kg).  
Ultrasound measurements were performed using an Aloka SSD-500 V ultrasound 
machine fitted with a 3.5-MHz transducer (Aloka Co. Ltd., Wallingford, CT). Image 
interpretation was performed using Rib-O-Matic 3.5 software (Critical Visions Inc., Atlanta, 
GA). Measurement of back fat thickness, ribeye area, and IMF commenced at the time of 
normal weaning and during the finishing phase to predict the end point of the fattening period 
(target harvest back fat thickness of 1.1 cm). 
Steers received a dose of 4 pellets containing a total of 80 mg of trenbolone acetate 
and 16 mg estradiol (COMPONENT® TE-IS by ELANCO, Ivy Animal Health, Inc., 
Overland Park, KS, USA) at ~140 days of age. In the finishing phase (day 101 after early 
weaning), steers were re-implanted with a dose of 6 pellets containing a total of 120 mg of 
trenbolone acetate and 24 mg estradiol. 
Steers were harvested at a commercial facility (Tyson, East Moline, IL, USA), where 
data on hot carcass weight (HCW), 12th to 13th rib fat thickness (BF), ribeye area (REA), 
kidney, pelvic, and heart fat (KPH), and marbling score were collected. The amount of 
boneless, closely trimmed retail cuts from the high-value parts of the carcass (round, loin, rib, 
and chuck), i.e. Yield Grade (YG), was calculated by evaluating the amount of external fat, 
hot carcass weight, amount of KPH, and the REA, using the formula  = [2.5 + 2.5 × (inches 
of BF) + 0.20 × (percentage of KPH) + 0.0038 × (lb of HCW) − 0.32 × (REA in square 
inches) ] (Taylor 1994). 
Statistical Analysis 
Quantitative PCR data were analyzed using the MIXED procedure of SAS (SAS 9.1 
Institute, Cary, NC, USA). Before statistical analysis, normalized qPCR data were 
transformed to fold-change relative to day 0 (i.e. early weaning day) (Bionaz and Loor 2011). 
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To estimate standard errors at day 0 and prevent biases in statistical analysis, normalized 
qPCR data were transformed to obtain a perfect mean of 1.0 at day 0, leaving the proportional 
difference between the biological replicate. The same proportional change was calculated at 
all other time points to obtain a fold-change relative to day 0. Fixed effects in the statistical 
model for each variable analyzed (i.e. genes) included treatment, time on experiment, and 
treatment × time on experiment when appropriate (i.e. for mRNA expression over time). 
Gene expression data analysis included a repeated-measures statement with an autoregressive 
covariate structure. Animal performance, ultrasound and carcass data was also analyzed using 
the MIXED procedure of SAS, and treatment was the fixed effect in the statistical model. The 
random effect in all models was steer within treatment. Pearson correlation analysis among 
genes was conducted using PROC CORR in SAS. 
RESULTS 
Animal Performance 
Between 0 and 96 days after early weaning (i.e. the growing phase) there was a clear 
difference among treatments with an ADG in EWS steers that was 0.2 kg/d greater compared 
with NWS and 0.6 kg/d greater compared with NWN. Between 96 – 240 days there was a 
clear difference in ADG being higher for NWS and NWN compared to EWS. The average 
time required to harvest steers was quite similar across treatments, 371 ± 8, 363 ± 8 and 369 
± 8 days for EWS, NWS and NWN, respectively. During the finishing phase (96 vs. 240), 
EWS steers had lower feed efficiency compared to NWS and NWN (Table 6). Dry matter 
intake for all groups was measured from 100 days after early weaning until slaughter. The 
EWS steers consumed more feed in the first two weeks after normal weaning compared to 
NWS and NWN (Supplemental Figure 1).  
The ultrasound data are reported in Table 7. Marbling score (i.e. a measure of IMF 
deposition) was greatest for EWS, intermediate for NWS, and lowest for NWN. Clear 
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differences in marbling score were observed between EWS and NWN. There was no 
significant difference in marbling score between EWS and NWS steers (526 and 503, 
Modest), but it was greater for both treatments compared with NWN (471, Small). Rib eye 
area (REA) and back fat thickness were not significantly different among treatments.  
The carcass traits are reported in Table 7. The carcass quality parameter that was most 
affected was marbling, with higher values in EWS steers compared with NWS and NWN 
steers. These marbling results led to a greater percentage of steers grading Choice or greater 
(data not shown). There was no difference in HCW between EWS, NWS and NWN steers. 
Percentage of camera yield grade, kidney, pelvic and heart fat (KPH) also did not differ (P = 
0.35), with lower values for all the treatments compared with the carcass standardized 
average of 3.5% (Hale 2010). 
Gene Expression 
Results for YY1 indicated that there was no time × treatment effect (P = 0.34) but 
there was a time effect (P < 0.01), i.e. expression of YY1 increased throughout the study with 
highest expression at 240 d (Figure 2). Among genes directly linked with YY1, there was a 
treatment × time interaction (P = 0.06) for RXRB due to greater expression for NWN and 
EWS vs. NWS at 96 d but, also due to lower expression for EWS and NWS vs. NWN at 240 
d. RXRB due to EWS and NWS vs. NWN had a strong negative correlation with YY1 and a 
positive correlation with VDR, IGFBP5 and STAT5B (Supplemental table 1). 
In the case of VDR, there was a significant (P = 0.001) treatment × time interaction 
due to a gradual increase in expression during the growing phase with both EWS and NWN 
vs. NWS. Expression of VDR was lower during the finishing phase with EWS but remained 
constant with NWS and NWN. Overall expression of VDR at 240 days was highest for 
NWN, intermediate with EWS, and lowest with NWS. There was a strong negative 
correlation between VDR with YY1 in animals in NWS; whereas, there was a positive 
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correlation between YY1 with both KAT2B and PPARG in NWN, with IGFBP5 and 
STAT5B in NWS, and with IGFBP5, PPARG and KAT2B in EWS (Supplemental Table 1). 
There was a treatment × time interaction (P < 0.01) for the expression of PPARG due 
to a gradual increase between 0 and 96 d at which point expression was highest with EWS 
compared with NWS and NWN. During the finishing phase, expression of PPARG remained 
higher with EWS and also NWS, while it decreased due to NWN. Thus, at 240 days the 
expression of PPARG was markedly higher for EWS and equal for NWS and NWN (P < 
0.01). In the EWS group, there was a positive correlation with IGFBP5 and KAT2B. 
However, in NWS and NWN there was a strong negative correlation between PPARG with 
STAT5B and in NWS between YY1, GTF2B and KAT2B (Supplemental Table 1). 
There was a time × treatment interaction (P < 0.01) for IGFBP5. due namely to a 
longitudinal increase in expression with EWS but a decrease with both NWP and NWN 
leading to greater expression with EWS at 96 and 240 d (Figure 3). In the NWS group, there 
was a negative correlation between YY1 and IGFBP5 and a strong positive correlation 
between YY1 with STAT5B. In the EWS group, there was a positive correlation between 
IGFBP5 with KAT2B and STAT5B (Supplemental Table 1). 
In the case of GTF2B there was a time × treatment interaction (P < 0.01) due to a 
gradual increase in expression primarily with NWN compared with EWS and NWS. Both of 
those treatments had the same response during the growing and the finishing resulting in 
greater expression at 96 and 240 days vs. 0 d but never higher than NWN (Figure 3). In all 
treatments there was a marked positive correlation between GTF2B with YY1 and KAT2B. 
The correlation between GTF2B and PPARG was positive in the NWS group. However, a 
negative correlation was found between GTF2B and STAT5B in the NWN group 
(Supplemental Table 1). 
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Expression of KAT2B had a time × treatment effect (P = 0.02) due to a longitudinal 
increase in expression that was lower with NWS at 96 d and, with both NWS and EWS than 
NWN at 240 d. During the finishing period, all treatments had greater expression relative to 0 
and 96 d but at 240 d expression was highest with NWN, intermediate with EWS, and lowest 
with NWS (Figure 3). In the EWS group, there was a positive correlation between KAT2B 
with GTF2B, IGFBP5, PPARG, STAT5B, VDR and YY1. In the NWS group there was a 
positive correlation between KAT2B with GTF2B, PPARG and RXRB. In the NWN group 
there was a positive correlation between KAT2B with GTF2B, VDR, and YY1 
(Supplemental Table 1). 
DISCUSSION 
Animal Performance 
The greater ADG during the growing phase that we observed with EWS and NWS are 
consistent with previous work (Graugnard et al. 2010; Myers et al. 1999b). However, the 
greater ADG in NWS and NWN steers during the finishing phase, which had an inferior 
performance than EWS during the growing phase, may have been due to compensatory gain 
as also reflected by the greater efficiency of feed conversion during that time (Table 6). 
Previous studies with EW calves have shown variable responses in terms of feed efficiency 
during the finishing phase (Myers et al. 1999a) (Barker-Neef et al. 2001; Graugnard et al. 
2010; Myers et al. 1999b), but our data with EWS confirmed the lack of benefit of high-
starch during the growing phase in terms of improved feed efficiency during finishing 
(Graugnard et al. 2010; Graugnard et al. 2009). 
Greater marbling scores in EWS steers were likely due to the early feeding of starch 
(Graugnard et al. 2010), which enhanced ruminal propionate production with an resulting 
increase in serum insulin and glucose concentrations (Schoonmaker et al. 2004). Propionate 
is the major glucogenic volatile fatty acid, thus, more glucose is generated in the liver, 
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resulting in more net energy available to the animal. A pro- insulinemic response would have 
led to greater glucose uptake by adipose, while inhibiting breakdown of fat and protein in 
skeletal muscle (Johnson et al. 1982). Despite the similar amount of time required for all 
steers to reach the point of harvest, EWS steers clearly had longer access to the high-starch 
diet that is more typical of the finishing phase, i.e. they were more efficient early on and the 
molecular mechanisms driving marbling deposition were probably activated ahead of normal 
as we have seen previously (Graugnard et al. 2010). According to Faulkner, D. (1994) 
(Faulkner et al. 1994), calves must be creep-fed for about 80 days to express its potential for 
marbling deposition, thus, despite NWS steers receiving creep feed for a period of 96 days 
that in itself did not enhance marbling relative to steers receiving milk and pasture as their 
sole source of feed (NWN) . Our results underscore the potential for precocious initiation of 
marbling in young animals fed higher dietary starch. 
Yin Yang 1 Network Gene Expression 
Although PPARG has not been shown to be a direct target of YY1, it was 
demonstrated that YY1 binds and represses PPARD leading to inhibition of ligand-induced 
transcription activity (He et al. 2008), it could be possible that YY1 in skeletal muscle exerts 
some inhibition over PPARG which seems to be supported by the contrasting response in 
expression of PPARG and YY1 specifically in the EWS group (Figure 2). Those animals had 
greater marbling deposition and PPARG expression, thus, supporting the existence of a more 
robust adipogenic/lipogenic program in those animals. Another important component of the 
PPARG transcriptional complex in some cellular systems is peroxisomal proliferator-
activated receptor gamma coactivator 1 alpha (PPARGC1A), which interacts with YY1 to 
form a transcriptional complex in some cell types (Cunningham et al. 2007). PPARGC1A 
binds to PPARG in a ligand independent manner (Puigserver et al. 1998). The interaction 
between PPARG and PPARGC1A is crucial for the generation of brown adipose tissue 
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(BAT) (Nedergaard et al. 2005). Whether the same is true for white adipose tissue (WAT)  is 
unknown. 
The bioinformatics analysis using IPA of microarray data from Longissimus muscle 
samples in our previous study (Moisá 2011) revealed that the complex formed between VDR 
and RXR is affected by YY1. Transcription Factor 2 B (TFIIB) and CREB binding protein 
(CBP) bind to YY1 and regulate activation of transcription via 1,25-(OH)2D3 through an 
alleviation of the repressive effect induced upon YY1 binding to VDR (Raval-Pandya et al. 
2001). YY1 also competes for the VDRE with TFIIB through protein-protein interactions 
(Guo et al. 1997). Thus, it has been speculated that maximizing suppression of vitamin D 
induction when a target gene is not transcriptionally active may enhance affinity of YY1 for 
VDRE (Lian et al. 2001). The end result would be the maintenance of basal transcription but 
inhibition of vitamin D sensitivity. 
In quiescent NIH3T3 cells, YY1 expression was low or absent but was rapidly 
stimulated by exposure to serum containing IGF-1 (Flanagan 1995). The rapid responses of 
YY1 expression to growth factor deprivation suggested the possibility that YY1 may mediate 
some of the intranuclear responses to stimulation by IGF-1 (Flanagan 1995). Baritaki, S. 
(2009) reported a dependence of YY1 expression on IGF-1 levels in human brain tumors , 
suggesting that inhibition of IGF-1-induced proliferation might also encompass inhibition of 
YY1 (Baritaki et al. 2009). Most IGF-I in the circulation is bound to IGFBP, which can either 
inhibit or facilitate IGF-I binding to the IGF-I receptor (Duan 2002). IGFBP-3 and IGFBP-5 
have been implicated in inhibition of cell proliferation via IGF-I resulting in depressed 
muscle growth (Yang et al. 1999). Although we did not measure blood IGF-1 concentration, 
it was interesting that longitudinal expression of IGFBP5 in the NWS and NWN groups 
followed a different pattern than EWS. IGFBP5 is a YY1 target gene identified in mouse 
embryonic fibroblasts (MEFs) cells (Affar el et al. 2006) and it has been implicated in muscle 
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cell growth and differentiation (Lehnert et al. 2007). In rats, IGFBP5 mRNA also was 
detected in white adipose tissue, kidney, skeletal muscle and heart (Gosteli-Peter et al. 1994). 
Steers compared with heifers typically have greater IGFBP5 expression in Longissimus 
muscle and IGF-1 in serum (Walker et al. 2010). However, injection with Ractopamine 
produced a decrease in mRNA expression of IGFBP5 in steers but an increase in heifers 
(Walker et al. 2010). The fact that all steers received implants regardless of treatment group 
and IGFBP5 expression differ suggests that the mechanism driving the longitudinal 
expression of this gene was probably related with a transcription factor. 
In human embryonic kidney cells, IGFBP5 is both a PPAR and VDR target gene 
(Degenhardt et al. 2006). PPARs are fatty acid sensors, whereas VDR acts as a sensor for the 
metabolites of vitamin D. Both nuclear receptors are involved in regulation of vital metabolic 
reactions as well as cellular growth (Degenhardt et al. 2006). Matilainen, M. (2005) 
confirmed that IGFBP1, 3 and 5 are primary 1α,25(OH)2D3 target genes and that each one is 
under the control of multiple VDRE (Matilainen et al. 2005). In cultured C2C12 myoblast 
cells and in primary skeletal muscle cells during early stages of myogenesis, IGFBP5 
enhanced myogenic differentiation by activation of the IGF-IR-PI3K-Akt signaling pathway 
leading to an increase in Myogenin expression (Ren et al. 2008). 
Although we did not measure blood IGF-1 concentration, in a previous study early 
weaning of calves (90 days of age) resulted in greater ADG (P = 0.001) and blood IGF-1 
concentration (P = 0.001) (Blanco 2009). IGF-1 is produced primarily by the liver as an 
endocrine hormone stimulated by growth hormone (GH) and its effect can be delayed by 
undernutrition, growth hormone insensitivity, lack of growth hormone receptors, or failure of 
the downstream signaling pathway post GH receptor including STAT5B (Davey et al. 2001). 
IGFBP-5 normally inhibits muscle differentiation, which underscores a role for IGFBP-5 in 
regulating IGF-1 action during myogenesis in vivo in bovine (Lehnert et al. 2007) and 
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rodents (James et al. 1996). However, recent transcriptomics work on bovine muscle 
development by Lehnert, R. (2007) suggest that, in bovine C2 myocytes cells, IGFBP5 may 
enhance muscle cell growth and differentiation (Lehnert et al. 2007). 
Although steers in EWS had greater ADG during the growing phase only, expression 
of IFGBP5 remained elevated compared with NWS and NWN throughout the study (Figure 
3), which seems to suggest that the myogenic process was enhanced at an early age due to 
greater nutrient availability. It is also noteworthy that during the finishing phase and despite 
the compensatory gain in the NWS and NWN groups, expression of IGFBP5 did not seem to 
be associated with the greater ADG and efficiency of feed conversion. This suggests that 
transcription of IGFBP5 was likely not associated with muscle development, perhaps because 
a critical window was missed. Overall, it would appear that enhancing dietary starch at an 
early age triggers hormonal adaptations favoring not only adipogenesis but also myogenesis 
(Bonnet 2010). 
Work in non-ruminants showed that YY1 is a component of the growth hormone-
inducible nuclear factor complex (GHINF), which exerts close regulation of STAT5B 
transcription (Bergad et al. 1995). Since the distribution and function of each STAT (STAT 
1, 2, 3, 4, 5A, 5B and 6) is unique, the regulation of tissue specific genes may be a 
physiological role for these proteins (Schindler and Darnell 1995). In adipose tissue, 
STAT5B activation is highly specific and only GH was able to cause STAT5B to translocate 
to the nucleus upon activation (Balhoff and Stephens 1998). Interestingly, YY1 is associated 
with STAT5B during the response to GH in adipose tissue (Bergad et al. 1995). GH-activated 
STAT5B can inhibit PPAR-regulated transcription. This inhibitory crosstalk is mutual, i.e. 
GH-induced-STAT5B can be inhibited by ligand-activated PPARA or PPARG (Shipley and 
Waxman 2003). Although, it has been hypothesized that STATs play a regulatory function in 
adipocyte gene expression, their particular functions during adipogenesis or in the mature 
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adipocyte are mainly unknown (Stephens et al. 1999). Results fron this study showed a clear 
inhibition of STAT5B expression during the entire study, i.e. during development, which may 
be partly explained by the upregulation of PPARG. Such mechanism was most evident in the 
EWS group which also had greater marbling deposition in the carcass. 
GTF2B/TFIIB (General transcription factor IIB) is one of the ubiquitous TF required 
for transcription initiation [i.e. formation of the preinitiation complex (PIC)] by RNA 
polymerase II (RNAP II) (Crown Human Genome Center 2011). The rate of RNAP II-
directed transcription is affected by VDR (Zawel and Reinberg 1995).YY1 represses Vitamin 
D receptor-mediated 25-Hydroxy-vitaminD3-24-hydroxylase transcription by sequestering 
TFIIB/CBP. In addition, the N-terminal region of cAMP response element-binding protein 
(CBP) that interacts with YY1 can inhibit YY1 from binding to TFIIB. Thus, CBP may 
diminish YY1-mediated repression by preventing YY1 from binding to TFIIB, which is 
required for VDR-mediated transcription (Raval-Pandya et al. 2001). 
Based on our previous work with similar treatments (Graugnard et al. 2010), in this 
study it was anticipated that due to the level of dietary starch in the EWS and NWS 
treatments, the adipogenic response assessed via PPARG and marbling would have been 
more robust relative to NWN. Although that was the case for EWS, expression of GTF2B 
was markedly greater in the NWN group which did not have greater PPARG or marbling 
relative to EWS or NWS. A possible explanation for this contrasting response could be that, 
although the formation of the PIC complex to promote adipogenic transcription seemed to 
have been facilitated by the greater expression of GTF2B in the NWN treatment, the fact that 
expression of PPARG was lower meant that there was a suboptimal pro-adipogenic 
environment. 
Although there was no meaningful correlation between VDR and GTF2B, there was a 
strong positive correlation between YY1 and GTF2B particularly in the NWN group. This 
78 
 
could have facilitated the assembly of the PIC complex, because the relative increase in YY1 
expression was greater than GTF2B. These observations seem to suggest that there was a 
YY1-related inhibition of GTF2B interaction with the heterodimer complex, resulting in an 
inhibition of PIC complex binding to VDR/RXRB, thus, precluding the transcriptional 
process to begin. 
Activity of YY1 is regulated through histone acetylation by p300 (KAT3B) and 
PCAF (KAT2B), deacetylation by HDAC1, 2 and 3, and through recognition of the cognate 
DNA sequence affected by acetylation and deacetylation of the YY1 protein (Yao et al. 
2001). The p300/CBP and PCAF coactivators have acetyltransferase activity and regulate 
transcription, cell cycle progression, and differentiation . Both are required for MyoD activity 
and muscle differentiation. The acetyltransferase activity of PCAF, but not of p300, is 
involved in controlling myogenic transcription and differentiation (Puri et al. 1997; Sartorelli 
et al. 1999). CBP and p300 are indispensable for the complete activation of PPARG and 
adipocyte differentiation, but CBP and p300 are not mutually complemented in the process 
(Takahashi et al. 2002). Furthermore, CBP+/- mice display reduced weight of WAT due to 
reduced triglyceride accumulation in WAT, but no BAT phenotype. There are several 
indications showing the role as coactivators of CBP and p300 in adipogenesis, but additional 
studies are required to establish how PPARG, p300 and CBP cooperate to regulate 
adipogenesis in both WAT and BAT (Koppen and Kalkhoven 2010). In this study, there was 
a positive correlation between KAT2B and YY1 in all treatments. Such response seems to 
suggest that KAT2B could have promoted acetylation of YY1 , thus, promoting the YY1 
corepresor activity on the binding between GTF2B and VDR/RXRB complex.  
SUMMARY AND CONCLUSIONS 
In summary, administration of starch in the diet of early weaned steers early in life, 
was expressed in higher scores for intramuscular fat deposition compared with normal 
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weaned steers that received (NWS) and did not received creep feeding (NWN). This result 
make the animal husbandry practice of early weaning, more interesting to the eyes of the beef 
producers. Application of these husbandry techniques in Angus calves, appeared to induce 
precocious pre-adipocyte differentiation and lipid filling through up-regulation of PPARG 
and its target genes. Even though YY1 did not present changes due to starch level on diet, an 
ascendant expression through growing phase to finishing phase was noticeable. Moreover, 
there was not a direct effect of YY1 as a regulator of adipocyte differentiation, but there were 
indirect effects by means of YY1 target genes. There were more significant positive 
interaction between genes belonging to YY1 network in EWS treatment. IGFBP5 which is 
both, PPAR and VDR target gene was the most clear enhancer of adipocyte differentiation. 
This was noticeable in EWS steers by IGFBP5 expression that enhanced IGF-1 release, 
which stimulates adipocyte differentiation. 
Our data provided novel insights of potential gene networks with a feasible role in 
myogenesis and adipogenesis as affected by early administration of dietary starch level and 
weaning practices. However, YY1 knock out cell culture analysis might be the next step to 
assess the effect of YY1 in adipocyte differentiation in skeletal muscle samples from beef 
cattle. 
80 
 
REFERENCES 
Affar el B, Gay F, Shi Y, Liu H, Huarte M, Wu S, Collins T, and Li E. 2006. Essential 
dosage-dependent functions of the transcription factor yin yang 1 in late embryonic 
development and cell cycle progression. Mol Cell Biol 26(9):3565-3581. 
Ali YB, Carriere F, Verger R, Petry S, Muller G, and Abousalham A. 2005. Continuous 
monitoring of cholesterol oleate hydrolysis by hormone-sensitive lipase and other 
cholesterol esterases. J Lipid Res 46(5):994-1000. 
Allingham PG, East IJ, Kerlin RL, and Kemp DH. 1998. Digestion of host immunoglobulin 
and activity of midgut proteases in the buffalo fly Haematobia irritans exigua. J Insect 
Physiol 44(5-6):445-450. 
Anthonsen MW, Ronnstrand L, Wernstedt C, Degerman E, and Holm C. 1998. Identification 
of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in 
response to isoproterenol and govern activation properties in vitro. J Biol Chem 
273(1):215-221. 
Archile-Contreras AC, Cha MC, Mandell IB, Miller SP, and Purslow PP. 2011. Vitamins E 
and C may increase collagen turnover by intramuscular fibroblasts. Potential for 
improved meat quality. J Agric Food Chem 59(2):608-614. 
Au Y. 2004. The muscle ultrastructure: a structural perspective of the sarcomere. Cell Mol 
Life Sci 61(24):3016-3033. 
Baldwin RL, Lin HJ, Cheng W, Cabrera R, and Ronning M. 1969. Enzyme and metabolite 
levels in mammary and abdominal adipose tissue of lactating dairy cows. J Dairy Sci 
52(2):183-187. 
Baldwin RL, Reichl JR, Louis S, Smith NE, Yang YT, and Osborne E. 1973. Effects of age, 
pregnancy, and lactation on rat, guinea pig, and cow adipose enzyme activities and 
cow adipose metabolism. J Dairy Sci 56(3):340-349. 
81 
 
Baldwin RL, and Smith NE. 1971. Intermediary aspects and tissue interactions of ruminant 
fat metabolism. J Dairy Sci 54(4):583-595. 
Balhoff JP, and Stephens JM. 1998. Highly specific and quantitative activation of STATs in 
3T3-L1 adipocytes. Biochem Biophys Res Commun 247(3):894-900. 
Barbosa-Sicard E, Markovic M, Honeck H, Christ B, Muller DN, and Schunck WH. 2005. 
Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C 
subfamily. Biochem Biophys Res Commun 329(4):1275-1281. 
Baritaki S, Chatzinikola AM, Vakis AF, Soulitzis N, Karabetsos DA, Neonakis I, Bonavida 
B, and Spandidos DA. 2009. YY1 Over-expression in human brain gliomas and 
meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels. Cancer 
Invest 27(2):184-192. 
Barker-Neef JM, Buskirk DD, Blackt JR, Doumit ME, and Rust SR. 2001. Biological and 
economic performance of early-weaned Angus steers. J Anim Sci 79(11):2762-2769. 
Bartlett K, and Eaton S. 2004. Mitochondrial beta-oxidation. Eur J Biochem 271(3):462-469. 
Bartness TJ, and Bamshad M. 1998. Innervation of mammalian white adipose tissue: 
implications for the regulation of total body fat. Am J Physiol 275(5 Pt 2):R1399-
1411. 
Bassett JM. 1977. Glucagon, insulin and glucose homeostasis in the fetal lamb. Ann Rech 
Vet 8(4):362-373. 
Batchvarova N, Wang XZ, and Ron D. 1995. Inhibition of adipogenesis by the stress-induced 
protein CHOP (Gadd153). EMBO J 14(19):4654-4661. 
Battaglia FC, and Meschia G. 1978. Principal substrates of fetal metabolism. Physiol Rev 
58(2):499-527. 
Bauman DE. 1976. Intermediary metabolism of adipose tissue. Fed Proc 35(11):2308-2313. 
82 
 
Bauman DE, J. W. Perfield II, M. J. de Veth, and A. L. Lock. 2003. New perspectives on 
lipid digestion and metabolism in ruminants. Proc Cornell Nutr Conf:175-189. 
Benne R, and Sloof P. 1987. Evolution of the mitochondrial protein synthetic machinery. 
Biosystems 21(1):51-68. 
Benson JD, and Emery RS. 1971. Fatty acid esterification by homogenates of bovine liver 
and adipose tissue. J Dairy Sci 54(7):1034-1040. 
Bergad PL, Shih HM, Towle HC, Schwarzenberg SJ, and Berry SA. 1995. Growth hormone 
induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-
related factor binding synergistically to two gamma-activated sites. J Biol Chem 
270(42):24903-24910. 
Bergman EN. 1968. Glycerol turnover in the nonpregnant and ketotic pregnant sheep. Am J 
Physiol 215(4):865-873. 
Bionaz M, and Loor JJ. 2011. Gene networks driving bovine mammary protein synthesis 
during the lactation cycle. Bioinform Biol Insights 5:83-98. 
Bionaz M.  R-Z, S. L., Everts, R. E., Lewin, H. A., Hurley, W. L., and Loor, J. J. . 2011. 
Dynamic Impact Approach - DIA. Urbana-Champaign Illinois: University of Illinois. 
Blanco  M, Villalba, D., Ripoll , G., Sauerwein , H., Casasús, I. 2009. Effects of early 
weaning and breed on calf performance and carcass and meat quality in autumn-born 
bull calves. Livestock Science 120:103–115. 
Bonnet M, Cassar-Malek, I., Chilliard, Y. and Picard, B. 2010. Ontogenesis of muscle and 
adipose tissues and their interactions in ruminants and other species. Animal 4:1093-
1109. 
Bray GA. 2004. How do we get fat? An epidemiologic and metabolic approach. Clin 
Dermatol 22(4):281-288. 
83 
 
Buchanan-Smith JG, Horney FD, Usborne WR, and Burgess TD. 1973. Effects of feeding a 
zero- or high-roughage diet to cattle upon adipose tissue lipogenesis. Can J Physiol 
Pharmacol 51(7):532-538. 
Byrne KA, Wang YH, Lehnert SA, Harper GS, McWilliam SM, Bruce HL, and Reverter A. 
2005. Gene expression profiling of muscle tissue in Brahman steers during nutritional 
restriction. J Anim Sci 83(1):1-12. 
Chen S, Costa CH, Nakamura K, Ribeiro RC, and Gardner DG. 1999. Vitamin D-dependent 
suppression of human atrial natriuretic peptide gene promoter activity requires 
heterodimer assembly. J Biol Chem 274(16):11260-11266. 
Cianzio DS, Topel DG, Whitehurst GB, Beitz DC, and Self HL. 1985. Adipose tissue growth 
and cellularity: changes in bovine adipocyte size and number. J Anim Sci 60(4):970-
976. 
Clarke SL, Robinson CE, and Gimble JM. 1997. CAAT/enhancer binding proteins directly 
modulate transcription from the peroxisome proliferator-activated receptor gamma 2 
promoter. Biochem Biophys Res Commun 240(1):99-103. 
Claycomb JM, and Orr-Weaver TL. 2005. Developmental gene amplification: insights into 
DNA replication and gene expression. Trends Genet 21(3):149-162. 
Considine RV, Nyce MR, Morales LM, Magosin SA, Sinha MK, Bauer TL, Rosato EL, 
Colberg J, and Caro JF. 1996. Paracrine stimulation of preadipocyte-enriched cell 
cultures by mature adipocytes. Am J Physiol 270(5 Pt 1):E895-899. 
Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk ML, 
Potts JL, and Hockaday TD. 1992. Adipose tissue metabolism in obesity: lipase action 
in vivo before and after a mixed meal. Metabolism 41(3):264-272. 
84 
 
Crandall DL, Hausman GJ, and Kral JG. 1997. A review of the microcirculation of adipose 
tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4(2):211-
232. 
Crown Human Genome Center DoMG, the Weizmann Institute of Science. 2011. Gene Cards 
Humans - General Transcription Factor IIB. 
Cummings CA, and Relman DA. 2000. Using DNA microarrays to study host-microbe 
interactions. Emerg Infect Dis 6(5):513-525. 
Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, and Puigserver P. 2007. 
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha 
transcriptional complex. Nature 450(7170):736-740. 
Darlington GJ, Ross SE, and MacDougald OA. 1998. The role of C/EBP genes in adipocyte 
differentiation. J Biol Chem 273(46):30057-30060. 
Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, and Grattan DR. 2001. 
STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 
142(9):3836-3841. 
Deeth HC, and Christie WW. 1979. Biosynthesis of triacylglycerols in ovine adipose tissue in 
vitro. Int J Biochem 10(7):577-582. 
Degenhardt T, Matilainen M, Herzig KH, Dunlop TW, and Carlberg C. 2006. The insulin-
like growth factor-binding protein 1 gene is a primary target of peroxisome 
proliferator-activated receptors. J Biol Chem 281(51):39607-39619. 
Denton RM, Randle PJ, Bridges BJ, Cooper RH, Kerbey AL, Pask HT, Severson DL, 
Stansbie D, and Whitehouse S. 1975. Regulation of mammalian pyruvate 
dehydrogenase. Mol Cell Biochem 9(1):27-53. 
Desvergne B, Michalik L, and Wahli W. 2006. Transcriptional regulation of metabolism. 
Physiol Rev 86(2):465-514. 
85 
 
Drackley JK. 2004. Overview of Fat Digestion and Metabolism in Dairy Cows. In: University 
of Illinois U, editor. The purpose of this paper is to provide an overview of the 
processes of fat digestion and 
use in dairy cows. This is presented as a practical, “hands-on” approach rather than as a 
scientific review; consequently, scientific references are not included. Interested readers 
should 
feel free to contact the author if more information or scientific documentation is needed. ed. 
Urbana, IL. p 9. 
Duan C. 2002. Specifying the cellular responses to IGF signals: roles of IGF-binding 
proteins. J Endocrinol 175(1):41-54. 
Evans K, Burdge GC, Wootton SA, Clark ML, and Frayn KN. 2002. Regulation of dietary 
fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 
51(9):2684-2690. 
Eversole DE. 2009. Creep feeding beef calves. Virginia: Virginia Cooperative Extension-
Virginia State University. p 5. 
Everts RE, Band MR, Liu ZL, Kumar CG, Liu L, Loor JJ, Oliveira R, and Lewin HA. 2005. 
A 7872 cDNA microarray and its use in bovine functional genomics. Vet Immunol 
Immunopathol 105(3-4):235-245. 
Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, Fruchart JC, Briggs M, 
Spiegelman BM, and Auwerx J. 1999. Regulation of peroxisome proliferator-
activated receptor gamma expression by adipocyte differentiation and determination 
factor 1/sterol regulatory element binding protein 1: implications for adipocyte 
differentiation and metabolism. Mol Cell Biol 19(8):5495-5503. 
86 
 
Faraj M, Lu HL, and Cianflone K. 2004. Diabetes, lipids, and adipocyte secretagogues. 
Biochem Cell Biol 82(1):170-190. 
Faulconnier Y, Ortigues-Marty, I., Delavaud, C., Dozias, D., Jailler, R., Micol, D. and 
Chilliard, Y. 2007. Influence of the diet and grazing on adipose tissue lipogenic 
activities and plasma leptin in steers. Animal 1(9):1263–1271. 
Faulkner DB, Hummel DF, Buskirk DD, Berger LL, Parrett DF, and Cmarik GF. 1994. 
Performance and nutrient metabolism by nursing calves supplemented with limited or 
unlimited corn or soyhulls. J Anim Sci 72(2):470-477. 
Feingold KR, Zsigmond G, Hughes-Fulford M, Lear SR, and Moser AH. 1985. The effect of 
diabetes mellitus on the lymphatic transport of intestinal sterols. Metabolism 
34(12):1105-1109. 
Fielding BA, and Frayn KN. 1998. Lipoprotein lipase and the disposition of dietary fatty 
acids. Br J Nutr 80(6):495-502. 
Flanagan JR. 1995. Autologous stimulation of YY1 transcription factor expression: role of an 
insulin-like growth factor. Cell Growth Differ 6(2):185-190. 
Garcia-Rojas P, Antaramian A, Gonzalez-Davalos L, Villarroya F, Shimada A, Varela-
Echavarria A, and Mora O. 2010. Induction of peroxisomal proliferator-activated 
receptor gamma and peroxisomal proliferator-activated receptor gamma coactivator 1 
by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained 
from bovine white adipose tissue1,2. J Anim Sci 88(5):1801-1808. 
Goldberg IJ. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism 
and atherogenesis. J Lipid Res 37(4):693-707. 
Gorocica-Buenfil MA, Fluharty FL, Reynolds CK, and Loerch SC. 2007. Effect of dietary 
vitamin A restriction on marbling and conjugated linoleic acid content in Holstein 
steers. J Anim Sci 85(9):2243-2255. 
87 
 
Gosteli-Peter MA, Winterhalter KH, Schmid C, Froesch ER, and Zapf J. 1994. Expression 
and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein 
messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with 
IGF-I and growth hormone. Endocrinology 135(6):2558-2567. 
Graugnard DE. 2011. Immune function, gene expression, blood indices and performance in 
transition dairy cows affected by diet and inflammation. Urbana-Champaign: 
University of Illinois. 
Graugnard DE, Berger LL, Faulkner DB, and Loor JJ. 2010. High-starch diets induce 
precocious adipogenic gene network up-regulation in longissimus lumborum of early-
weaned Angus cattle. Br J Nutr 103(7):953-963. 
Graugnard DE, Piantoni P, Bionaz M, Berger LL, Faulkner DB, and Loor JJ. 2009. 
Adipogenic and energy metabolism gene networks in longissimus lumborum during 
rapid post-weaning growth in Angus and Angus x Simmental cattle fed high-starch or 
low-starch diets. BMC Genomics 10:142. 
Green H, and Kehinde O. 1974. Sublines of Mouse 3t3 Cells That Accumulate Lipid. Cell 
1(3):113-116. 
Gregoire FM, Smas CM, and Sul HS. 1998. Understanding adipocyte differentiation. Physiol 
Rev 78(3):783-809. 
Guo B, Aslam F, van Wijnen AJ, Roberts SG, Frenkel B, Green MR, DeLuca H, Lian JB, 
Stein GS, and Stein JL. 1997. YY1 regulates vitamin D receptor/retinoid X receptor 
mediated transactivation of the vitamin D responsive osteocalcin gene. Proc Natl 
Acad Sci U S A 94(1):121-126. 
Hale DS, Goodson, K., Savell, J. W. . 2010. Beef quality and yield grades. . Texas 
Department of Animal Science Texas AgriLife Extension Service College Station, TX 
77843-2471. p http://meat.tamu.edu/beefgrading.html. 
88 
 
Hanson RW, and Ballard FJ. 1967. The relative significance of acetate and glucose as 
precursors for lipid synthesis in liver and adipose tissue from ruminants. Biochem J 
105(2):529-536. 
Harper GS, and Pethick DW. 2004. How might marbling begin? Aust J Exp Agr 44(7):653-
662. 
He CQ, Ding NZ, and Fan W. 2008. YY1 repressing peroxisome proliferator-activated 
receptor delta promoter. Mol Cell Biochem 308(1-2):247-252. 
Head HH, Ventura M, Webb DW, and Wilcox CJ. 1970. Effect of growth hormone on 
glucose, nonesterified fatty acid and insulin levels, and on glucose utilization in dairy 
calves. J Dairy Sci 53(10):1496-1501. 
Hofmann SM, Zhou L, Perez-Tilve D, Greer T, Grant E, Wancata L, Thomas A, Pfluger PT, 
Basford JE, Gilham D et al. . 2007. Adipocyte LDL receptor-related protein-1 
expression modulates postprandial lipid transport and glucose homeostasis in mice. J 
Clin Invest 117(11):3271-3282. 
Hood RL, and Allen CE. 1973. Cellularity of bovine adipose tissue. J Lipid Res 14(6):605-
610. 
Hood RL, Thompson, E. H., Allen, C. E. 1972. The role of acetate, propionate and glucose as 
substrates for lipogenesis in bovine tissues. Int J Biochem 3:598-606. 
Howarth RE, Baldwin RL, and Ronning M. 1968. Enzyme activities in liver, muscle, and 
adipose tissue of calves and steers. J Dairy Sci 51(8):1270-1274. 
Huang HY, Li X, Liu M, Song TJ, He Q, Ma CG, and Tang QQ. 2008. Transcription factor 
YY1 promotes adipogenesis via inhibiting CHOP-10 expression. Biochem Biophys 
Res Commun 375(4):496-500. 
89 
 
James PL, Stewart CE, and Rotwein P. 1996. Insulin-like growth factor binding protein-5 
modulates muscle differentiation through an insulin-like growth factor-dependent 
mechanism. J Cell Biol 133(3):683-693. 
Johnson DD, Mitchell GE, Jr., Tucker RE, and Hemken RW. 1982. Plasma glucose and 
insulin responses to propionate in preruminating calves. J Anim Sci 55(5):1224-1230. 
Kanehisa MG, S. . 2011. KEGG - kyoto encyclopedia of genes and genomes. Nucleic Acids 
Res 28:27-30. 
Kather H, and Brand K. 1975. Origin of hydrogen required for fatty acid synthesis in isolated 
rat adipocytes. Arch Biochem Biophys 170(2):417-426. 
Kauraniemi P, Barlund M, Monni O, and Kallioniemi A. 2001. New amplified and highly 
expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA 
microarrays. Cancer Res 61(22):8235-8240. 
Kawada T, Kamei Y, and Sugimoto E. 1996. The possibility of active form of vitamins A and 
D as suppressors on adipocyte development via ligand-dependent transcriptional 
regulators. Int J Obes Relat Metab Disord 20 Suppl 3:S52-57. 
Kim KH, Lopez-Casillas F, Bai DH, Luo X, and Pape ME. 1989. Role of reversible 
phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis. FASEB 
J 3(11):2250-2256. 
King M. 2011a. Glucuronate Metabolism. The medical biochemistry page. 
King M. 2011b. VLDLs, IDLs, and LDLs. The medical biochemistry page. 
Kleinschmidt AK, Moss J, and Lane DM. 1969. Acetyl coenzyme A carboxylase: 
filamentous nature of the animal enzymes. Science 166(910):1276-1278. 
Klingenberg M. 1970. Metabolite transport in mitochondria: an example for intracellular 
membrane function. Essays Biochem 6:119-159. 
90 
 
Koppen A, and Kalkhoven E. 2010. Brown vs white adipocytes: the PPARgamma 
coregulator story. FEBS Lett 584(15):3250-3259. 
Lambert B, Godard C, and Jacquemin C. 1978. Studies on the sites of the antilipolytic action 
of insulin in adipose tissue. Biochim Biophys Acta 529(3):465-474. 
Lancaster P, Williams J, Corners J, Thompson L, McNamara D, and Ellersieck M. 2004. The 
effect of distillers dried grains with solubles as the protein source in a creep feed. 
Journal of Dairy Science 87:332-332. 
Lehnert SA, Byrne KA, Reverter A, Nattrass GS, Greenwood PL, Wang YH, Hudson NJ, and 
Harper GS. 2006. Gene expression profiling of bovine skeletal muscle in response to 
and during recovery from chronic and severe undernutrition. J Anim Sci 84(12):3239-
3250. 
Lehnert SA, Reverter A, Byrne KA, Wang Y, Nattrass GS, Hudson NJ, and Greenwood PL. 
2007. Gene expression studies of developing bovine longissimus muscle from two 
different beef cattle breeds. BMC Dev Biol 7:95. 
Leibel RL, Edens NK, and Fried SK. 1989. Physiologic basis for the control of body fat 
distribution in humans. Annu Rev Nutr 9:417-443. 
Lian JB, Stein JL, Stein GS, Montecino M, van Wijnen AJ, Javed A, and Gutierrez S. 2001. 
Contributions of nuclear architecture and chromatin to vitamin D-dependent 
transcriptional control of the rat osteocalcin gene. Steroids 66(3-5):159-170. 
Liang P, and Pardee AB. 1992. Differential display of eukaryotic messenger RNA by means 
of the polymerase chain reaction. Science 257(5072):967-971. 
Lieberman M, Marks, A. D., Smith, C. M. 2009. Carbohydrate Metabolism. In: Wilkins LW, 
editor. Marks' basic medical biochemistry: a clinical approach. 3rd ed. Philadelphia, 
PA 19106. p 481. 
91 
 
Londos C, Honnor RC, Dhillon GS, and Johnson DL. 1985. Lipolysis and cyclic-AMP-
dependent protein kinase in adipocytes: adenylate cyclase regulators versus insulin. 
Adv Cyclic Nucleotide Protein Phosphorylation Res 19:221-234. 
Loor JJ, Dann HM, Everts RE, Oliveira R, Green CA, Guretzky NA, Rodriguez-Zas SL, 
Lewin HA, and Drackley JK. 2005. Temporal gene expression profiling of liver from 
periparturient dairy cows reveals complex adaptive mechanisms in hepatic function. 
Physiol Genomics 23(2):217-226. 
Loor JJ, Dann HM, Guretzky NA, Everts RE, Oliveira R, Green CA, Litherland NB, 
Rodriguez-Zas SL, Lewin HA, and Drackley JK. 2006. Plane of nutrition prepartum 
alters hepatic gene expression and function in dairy cows as assessed by longitudinal 
transcript and metabolic profiling. Physiol Genomics 27(1):29-41. 
Loor JJ, Everts RE, Bionaz M, Dann HM, Morin DE, Oliveira R, Rodriguez-Zas SL, 
Drackley JK, and Lewin HA. 2007. Nutrition-induced ketosis alters metabolic and 
signaling gene networks in liver of periparturient dairy cows. Physiol Genomics 
32(1):105-116. 
Loor JJ, Moyes KM, and Bionaz M. 2011. Functional adaptations of the transcriptome to 
mastitis-causing pathogens: the mammary gland and beyond. J Mammary Gland Biol 
Neoplasia 16(4):305-322. 
Lowenstein JM. 1963. The supply of precursors for the extramitochondrial synthesis of fatty 
acids. Biochem Soc Symp 24:57-61. 
MacDougald OA, and Lane MD. 1995. Transcriptional regulation of gene expression during 
adipocyte differentiation. Annu Rev Biochem 64:345-373. 
Mahley RW, Hui DY, Innerarity TL, and Beisiegel U. 1989. Chylomicron remnant 
metabolism. Role of hepatic lipoprotein receptors in mediating uptake. 
Arteriosclerosis 9(1 Suppl):I14-18. 
92 
 
Maia MR, Chaudhary LC, Bestwick CS, Richardson AJ, McKain N, Larson TR, Graham IA, 
and Wallace RJ. 2010. Toxicity of unsaturated fatty acids to the biohydrogenating 
ruminal bacterium, Butyrivibrio fibrisolvens. BMC Microbiol 10:52. 
Marshall S, and Olefsky JM. 1979. Effects of lysosomotropic agents on insulin interactions 
with adipocytes. Evidence for a lysosomal pathway for insulin processing and 
degradation. J Biol Chem 254(20):10153-10160. 
Martin TG, Lemenager RP, Srinivasan G, and Alenda R. 1981. Creep Feed as a Factor 
Influencing Performance of Cows and Calves. Journal of Animal Science 53(1):33-
39. 
Matilainen M, Malinen M, Saavalainen K, and Carlberg C. 2005. Regulation of multiple 
insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. 
Nucleic Acids Res 33(17):5521-5532. 
May SG, Savell JW, Lunt DK, Wilson JJ, Laurenz JC, and Smith SB. 1994. Evidence for 
preadipocyte proliferation during culture of subcutaneous and intramuscular adipose 
tissues from Angus and Wagyu crossbred steers. J Anim Sci 72(12):3110-3117. 
McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, Smyth EM, and 
Reilly MP. 2009. Interferon gamma attenuates insulin signaling, lipid storage, and 
differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol 
Chem 284(46):31936-31944. 
Mears GJ, and Mendel VE. 1974. Correlation of food intake in lambs with adipocyte glucose 
metabolism and NEFA release. J Physiol 240(3):625-637. 
Menahan LA, Schultz LH, and Hoekstra WG. 1966a. Factors affecting ketogenesis from 
butyric acid in the ruminant. J Dairy Sci 49(7):835-845. 
93 
 
Menahan LA, Schultz LH, and Hoekstra WG. 1966b. Relationship of ketone body 
metabolism and carbohydrate utilization to fat mobilization in the ruminant. J Dairy 
Sci 49(8):957-961. 
Metz SH, and van den Bergh SG. 1972. Effects of volatile fatty acids, ketone bodies, glucose, 
and insulin on lipolysis in bovine adipose tissue. FEBS Lett 21(2):203-206. 
Moisá SJ, Graugnard DE, Berger LL, Faulkner DB, Rodriguez-Zas SL, Everts RE, Lewin 
HA, and Loor JJ. 2010. Longitudinal gene network and pathway analysis in skeletal 
muscle from early-weaned Angus steers fed high-starch or low-starch diets during the 
growing phase. Journal of Dairy Science 93(E-Suppl. 1):729. 
Moore JH, and Christie WW. 1979. Lipid metabolism in the mammary gland of ruminant 
animals. Prog Lipid Res 17(4):347-395. 
Morris KL, and Zemel MB. 2005. Effect of dietary carbohydrate source on the development 
of obesity in agouti transgenic mice. Obes Res 13(1):21-35. 
Moss J, Yamagishi M, Kleinschmidt AK, and Lane MD. 1972. Acetyl coenzyme A 
carboxylase. Purification and properties of the bovine adipose tissue enzyme. 
Biochemistry 11(20):3779-3786. 
Muller G, Over S, Wied S, and Frick W. 2008. Association of (c)AMP-degrading 
glycosylphosphatidylinositol-anchored proteins with lipid droplets is induced by 
palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes. 
Biochemistry 47(5):1274-1287. 
Muller G, Wied S, Dearey EA, and Biemer-Daub G. 2011. Glycosylphosphatidylinositol-
anchored proteins coordinate lipolysis inhibition between large and small adipocytes. 
Metabolism 60(7):1021-1037. 
94 
 
Myers SE, Faulkner DB, Ireland FA, Berger LL, and Parrett DF. 1999a. Production systems 
comparing early weaning to normal weaning with or without creep feeding for beef 
steers. J Anim Sci 77(2):300-310. 
Myers SE, Faulkner DB, Ireland FA, and Parrett DF. 1999b. Comparison of three weaning 
ages on cow-calf performance and steer carcass traits. J Anim Sci 77(2):323-329. 
Nedergaard J, Petrovic N, Lindgren EM, Jacobsson A, and Cannon B. 2005. PPARgamma in 
the control of brown adipocyte differentiation. Biochim Biophys Acta 1740(2):293-
304. 
Noble RC. 1980. Lipid metabolism in the neonatal ruminant. Prog Lipid Res 18:179-216. 
Okumura T, Saito K, Sakuma H, Nade T, Nakayama S, Fujita K, and Kawamura T. 2007. 
Intramuscular fat deposition in principal muscles from twenty-four to thirty months of 
age using identical twins of Japanese Black steers. J Anim Sci 85(8):1902-1907. 
Pelkonen R, Miettinen TA, Taskinen MR, and Nikkila EA. 1968. Effect of acute elevation of 
plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma 
insulin. Diabetes 17(2):76-82. 
Phan CT, and Tso P. 2001. Intestinal lipid absorption and transport. Front Biosci 6:D299-319. 
Piantoni P, Bionaz M, Graugnard DE, Daniels KM, Everts RE, Rodriguez-Zas SL, Lewin 
HA, Hurley HL, Akers M, and Loor JJ. 2010. Functional and gene network analyses 
of transcriptional signatures characterizing pre-weaned bovine mammary parenchyma 
or fat pad uncovered novel inter-tissue signaling networks during development. BMC 
Genomics 11:331. 
Pickworth CL, Loerch SC, Velleman SG, Pate JL, Poole DH, and Fluharty FL. 2011. 
Adipogenic differentiation state-specific gene expression as related to bovine carcass 
adiposity. J Anim Sci 89(2):355-366. 
95 
 
Pothoven MA, Beitz DC, and Thornton JH. 1975. Lipogenesis and lipolysis in adipose tissue 
of ad libitum and restricted-fed beef cattle during growth. J Anim Sci 40(5):957-962. 
Pothoven MA, Beitz DC, and Zimmerli A. 1974. Fatty acid compositions of bovine adipose 
tissue and of in vitro lipogenesis. J Nutr 104(4):430-433. 
Prior RL. 1978. Effect of level of feed intake on lactate and acetate metabolism and 
lipogenesis in vivo in sheep. J Nutr 108(6):926-935. 
Prior RL, and Jacobson JJ. 1979. Lactate, pyruvate and acetate interactions during in vitro 
lipogenesis in bovine adipose tissue. J Anim Sci 49(5):1410-1416. 
Puigserver P, Ribot J, Serra F, Gianotti M, Bonet ML, Nadal-Ginard B, and Palou A. 1998. 
Involvement of the retinoblastoma protein in brown and white adipocyte cell 
differentiation: functional and physical association with the adipogenic transcription 
factor C/EBPalpha. Eur J Cell Biol 77(2):117-123. 
Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko VV, Howard BH, Kedes L, Wang JY, 
Graessmann A, Nakatani Y et al. . 1997. Differential roles of p300 and PCAF 
acetyltransferases in muscle differentiation. Mol Cell 1(1):35-45. 
Purslow PP, Archile-Contreras AC, and Cha MC. 2011. Manipulating meat tenderness by 
increasing the turnover of intramuscular connective tissue. J Anim Sci. 
Raval-Pandya M, Dhawan P, Barletta F, and Christakos S. 2001. YY1 represses vitamin D 
receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of 
repression by CREB-binding protein. Mol Endocrinol 15(6):1035-1046. 
Rebouche CJ. 1991. Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr 54(6 
Suppl):1147S-1152S. 
Reilly PE, and Chandrasena LG. 1978. Glucose lactate interrelations in sheep. Am J Physiol 
235(5):E487-492. 
96 
 
Reiner A, Yekutieli D, and Benjamini Y. 2003. Identifying differentially expressed genes 
using false discovery rate controlling procedures. Bioinformatics 19(3):368-375. 
Ren H, Yin P, and Duan C. 2008. IGFBP-5 regulates muscle cell differentiation by binding to 
IGF-II and switching on the IGF-II auto-regulation loop. J Cell Biol 182(5):979-991. 
Rifkind AB, Lee, C., Chang, T. K. H. and Waxman, D. J. 1995. Arachidonic acid metabolism 
by human cytochrome P450s 2C8, 2C9, 2E1 and 1A2 : regioselective oxygenation 
and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in 
human liver microsomes. Archives of Biochemistry and Biophysics 320:380- 389. 
Rimm DL, Camp RL, Charette LA, Olsen DA, and Provost E. 2001. Amplification of tissue 
by construction of tissue microarrays. Exp Mol Pathol 70(3):255-264. 
Robinson GA, and Sutherland EW. 1971. On the relation of cyclic AMP to adrenergic 
receptors and sympathin. Adv Cytopharmacol 1:263-272. 
Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, and Spiegelman BM. 
2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. 
Genes Dev 16(1):22-26. 
Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, Wang JY, and Kedes 
L. 1999. Acetylation of MyoD directed by PCAF is necessary for the execution of the 
muscle program. Mol Cell 4(5):725-734. 
Savini I, Catani MV, Duranti G, Ceci R, Sabatini S, and Avigliano L. 2005. Vitamin C 
homeostasis in skeletal muscle cells. Free Radic Biol Med 38(7):898-907. 
Sawadogo M, and Sentenac A. 1990. RNA polymerase B (II) and general transcription 
factors. Annu Rev Biochem 59:711-754. 
Schena M, Shalon D, Davis RW, and Brown PO. 1995. Quantitative monitoring of gene 
expression patterns with a complementary DNA microarray. Science 270(5235):467-
470. 
97 
 
Schindler C, and Darnell JE, Jr. 1995. Transcriptional responses to polypeptide ligands: the 
JAK-STAT pathway. Annu Rev Biochem 64:621-651. 
Schoonmaker JP, Fluharty FL, and Loerch SC. 2004. Effect of source and amount of energy 
and rate of growth in the growing phase on adipocyte cellularity and lipogenic 
enzyme activity in the intramuscular and subcutaneous fat depots of Holstein steers. J 
Anim Sci 82(1):137-148. 
Senaratne RH, Dunphy, K.Y. 2009. Sulphur Metabolism in Mycobacteria. Mycobacterium: 
Genomics and Molecular Biology: Caister Academic Press. 
Shachter NS. 2001. Apolipoproteins C-I and C-III as important modulators of lipoprotein 
metabolism. Curr Opin Lipidol 12(3):297-304. 
Shapiro B. 1977. Lipid metabolism in mammals: Snyder, F. 
Shi Y, Lee JS, and Galvin KM. 1997. Everything you have ever wanted to know about Yin 
Yang 1. Biochim Biophys Acta 1332(2):F49-66. 
Shike DW, Faulkner, D. B., Cecava, M. J., Parrett, D. F. and Ireland, F. A. 2007. Effects of 
Weaning Age, Creep Feeding, and Type of Creep on Steer Performance, Carcass 
Traits and Economics. P Anim Sci 23:325-332. 
Shipley JM, and Waxman DJ. 2003. Down-regulation of STAT5b transcriptional activity by 
ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and 
PPARgamma. Mol Pharmacol 64(2):355-364. 
Smas CM, and Sul HS. 1995. Control of adipocyte differentiation. Biochem J 309 ( Pt 
3):697-710. 
Smit A, Hubley, R and Green, P. . 1999. RepeatMasker Open-3.0. 1996 ed: 
http://ftp.genome.washington.edu/. 
Smith S, Witkowski A, and Joshi AK. 2003. Structural and functional organization of the 
animal fatty acid synthase. Prog Lipid Res 42(4):289-317. 
98 
 
Smith SB, Gill, C. A., Lunt, D. K. and Brooks, M. A. 2009. Regulation of fat and fatty acid 
composition in beef cattle. Asian-Aust J Anim Sci 22(9):1125-1233. 
Smith SB, Lin KC, Wilson JJ, Lunt DK, and Cross HR. 1998. Starvation depresses 
acylglycerol biosynthesis in bovine subcutaneous but not intramuscular adipose tissue 
homogenates. Comp Biochem Physiol B Biochem Mol Biol 120(1):165-174. 
Smith SB, and Prior RL. 1981. Evidence for a functional ATP-citrate lyase:NADP-malate 
dehydrogenase pathway in bovine adipose tissue: enzyme and metabolite levels. Arch 
Biochem Biophys 211(1):192-201. 
Spiegelman BM, and Green H. 1980. Control of specific protein biosynthesis during the 
adipose conversion of 3T3 cells. J Biol Chem 255(18):8811-8818. 
Spiegelman BM, Kim JB, Wright HM, and Wright M. 1998. ADD1/SREBP1 activates PPAR 
gamma through the production of endogenous ligand. P Natl Acad Sci USA 
95(8):4333-4337. 
Stein CS, Martins I, and Davidson BL. 2000. Long-term reversal of hypercholesterolemia in 
low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated 
LDLR gene transfer combined with CD154 blockade. J Gene Med 2(1):41-51. 
Stein S, and Liang P. 2002. Differential display analysis of gene expression in mammals: a 
p53 story. Cell Mol Life Sci 59(8):1274-1279. 
Stephens JM, Morrison RF, Wu Z, and Farmer SR. 1999. PPARgamma ligand-dependent 
induction of STAT1, STAT5A, and STAT5B during adipogenesis. Biochem Biophys 
Res Commun 262(1):216-222. 
Student AK, Hsu RY, and Lane MD. 1980. Induction of fatty acid synthetase synthesis in 
differentiating 3T3-L1 preadipocytes. J Biol Chem 255(10):4745-4750. 
Taga H, Bonnet M, Picard B, Zingaretti MC, Cassar-Malek I, Cinti S, and Chilliard Y. 2011. 
Adipocyte metabolism and cellularity are related to differences in adipose tissue 
99 
 
maturity between Holstein and Charolais or Blond d'Aquitaine fetuses. J Anim Sci 
89(3):711-721. 
Takahashi N, Kawada T, Yamamoto T, Goto T, Taimatsu A, Aoki N, Kawasaki H, Taira K, 
Yokoyama KK, Kamei Y et al. . 2002. Overexpression and ribozyme-mediated 
targeting of transcriptional coactivators CREB-binding protein and p300 revealed 
their indispensable roles in adipocyte differentiation through the regulation of 
peroxisome proliferator-activated receptor gamma. J Biol Chem 277(19):16906-
16912. 
Tarr SL, Faulkner DB, Buskirk DD, Ireland FA, Parrett DF, and Berger LL. 1994. The value 
of creep feeding during the last 84, 56, or 28 days prior to weaning on growth 
performance of nursing calves grazing endophyte-infected tall fescue. J Anim Sci 
72(5):1084-1094. 
Taylor RE. 1994. Beef production and management decisions. New York: Macmillan 
Publishing  
Tempelman RJ. 2005. Assessing statistical precision, power, and robustness of alternative 
experimental designs for two color microarray platforms based on mixed effects 
models. Vet Immunol Immunopathol 105(3-4):175-186. 
Thornton J. 2011a. Circadian regulation of gene expression. In: Ensembl-EBI, editor. 
Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK. 
Thornton J. 2011b. Negative regulation of nucleotide metabolic processes In: Ensembl-EBI, 
editor. Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK. 
Tikkanen HO, Naveri H, and Harkonen M. 1996. Skeletal muscle fiber distribution influences 
serum high-density lipoprotein cholesterol level. Atherosclerosis 120(1-2):1-5. 
100 
 
Tokach RJ, Chung, K. Y. and Johnson, B. J. 2010. Factors affecting intramuscular adipose 
tissue development in beef cattle. Department of Animal and Food Sciences, Texas 
Tech University, Lubbock 79409. 
Trenkle A. 1978. Relation of hormonal variations to nutritional studies and metabolism of 
ruminants. J Dairy Sci 61(3):281-293. 
Umek RM, Friedman AD, and McKnight SL. 1991. CCAAT-enhancer binding protein: a 
component of a differentiation switch. Science 251(4991):288-292. 
Vaz FM, and Wanders RJ. 2002. Carnitine biosynthesis in mammals. Biochem J 361(Pt 
3):417-429. 
Vernon RG. 1980. Lipid metabolism in the adipose tissue of ruminant animals. Prog Lipid 
Res 19(1-2):23-106. 
Villarroya F, Giralt M, and Iglesias R. 1999. Retinoids and adipose tissues: metabolism, cell 
differentiation and gene expression. Int J Obes Relat Metab Disord 23(1):1-6. 
Virkel G, Lifschitz A, Sallovitz J, Ballent M, Scarcella S, and Lanusse C. 2009. Inhibition of 
cytochrome P450 activity enhances the systemic availability of triclabendazole 
metabolites in sheep. J Vet Pharmacol Ther 32(1):79-86. 
Vortherms TA, Nguyen CH, Bastepe M, Juppner H, and Watts VJ. 2006. D2 dopamine 
receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent. 
Neuropharmacology 50(5):576-584. 
Wahle KW. 1974. Desaturation of long-chain fatty acids by tissue preparations of the sheep, 
rat and chicken. Comp Biochem Physiol B 48(1):87-105. 
Walker DK, Titgemeyer EC, Baxa TJ, Chung KY, Johnson DE, Laudert SB, and Johnson BJ. 
2010. Effects of ractopamine and sex on serum metabolites and skeletal muscle gene 
expression in finishing steers and heifers. J Anim Sci 88(4):1349-1357. 
101 
 
Wallace AL, and Bassett JM. 1966. Effect of sheep growth hormone on plasma insulin 
concentration in sheep. Metabolism 15(2):95-97. 
Wang HI, P., Wilde, M. 2001. C/EBP-alpha arrests cell proliferation through direct inhibition 
of Cdk2 and Cdk4. Mol Cell 8:817-828. 
Wang YH, Byrne KA, Reverter A, Harper GS, Taniguchi M, McWilliam SM, Mannen H, 
Oyama K, and Lehnert SA. 2005. Transcriptional profiling of skeletal muscle tissue 
from two breeds of cattle. Mamm Genome 16(3):201-210. 
Wegner JA, E. Ender, K. 1998. Morphological aspects of subcutaneous and intramuscular 
adipocyte growth in cattle. Arch Tierz Dummerstorf 41:313-320. 
Wiegand G, and Remington SJ. 1986. Citrate synthase: structure, control, and mechanism. 
Annu Rev Biophys Biophys Chem 15:97-117. 
Williamson GaB, S. K. M. 1988. Purification of Glutathione - S - transferase from lean pork 
muscle and its reactivity with some lipid oxidation products. J Sci Food Agric 44:363-
374. 
Wu J, Srinivasan SV, Neumann JC, and Lingrel JB. 2005. The KLF2 transcription factor 
does not affect the formation of preadipocytes but inhibits their differentiation into 
adipocytes. Biochemistry 44(33):11098-11105. 
Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, and 
Spiegelman BM. 1999. Cross-regulation of C/EBP alpha and PPAR gamma controls 
the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3(2):151-
158. 
Yamazaki H, and Shimada T. 1999. Effects of arachidonic acid, prostaglandins, retinol, 
retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human 
cytochrome P450 enzymes. Xenobiotica 29(3):231-241. 
102 
 
Yang F, Johnson BJ, White ME, Hathaway MR, and Dayton WR. 1999. Effect of insulin-like 
growth factor (IGF)-I and Des (1-3) IGF-I on the level of IGF binding protein-3 and 
IGF binding protein-3 mRNA in cultured porcine embryonic muscle cells. J Cell 
Physiol 178(2):227-234. 
Yang YT, and Baldwin RL. 1973a. Lipolysis in isolated cow adipose cells. J Dairy Sci 
56(3):366-374. 
Yang YT, and Baldwin RL. 1973b. Preparation and metabolism of isolated cells from bovine 
adipose tissue. J Dairy Sci 56(3):350-365. 
Yao YL, Yang WM, and Seto E. 2001. Regulation of transcription factor YY1 by acetylation 
and deacetylation. Mol Cell Biol 21(17):5979-5991. 
Ye J, Cippitelli M, Dorman L, Ortaldo JR, and Young HA. 1996. The nuclear factor YY1 
suppresses the human gamma interferon promoter through two mechanisms: 
inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol 
16(9):4744-4753. 
Yeh LA, Lee KH, and Kim KH. 1980. Regulation of rat liver acetyl-CoA carboxylase. 
Regulation of phosphorylation and inactivation of acetyl-CoA carboxylase by the 
adenylate energy charge. J Biol Chem 255(6):2308-2314. 
Yoshinari K, Okino N, Sato T, Sugatani J, and Miwa M. 2006. Induction of detoxifying 
enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and 
antioxidants. Drug Metab Dispos 34(7):1081-1089. 
Yoshinari K, Sato T, Okino N, Sugatani J, and Miwa M. 2004. Expression and induction of 
cytochromes p450 in rat white adipose tissue. J Pharmacol Exp Ther 311(1):147-154. 
Yu YH, and Ginsberg HN. 2005. Adipocyte signaling and lipid homeostasis: sequelae of 
insulin-resistant adipose tissue. Circ Res 96(10):1042-1052. 
103 
 
Zawel L, and Reinberg D. 1995. Common themes in assembly and function of eukaryotic 
transcription complexes. Annu Rev Biochem 64:533-561. 
 
 
104 
 
Figures and Tables 
Table 5. Composition of the early weaned high-starch diet, the corn-grain-based creep 
supplement, and the finishing diet (dry matter basis) 
Ingredient Early weaned diet  Creep supplement Finishing diet 
Corn Husklage - - 64.2 
Ground Hay 16.2 - - 
Dry Whole Kernel Corn 66.8 82.0 - 
Dry Rolled Corn - - 10.1 
Wet Corn Gluten Feed - - 21.0 
Supplement a 17.0 17.9 - 
Supplement b - - 4.6 
a Composition of Growing Phase Supplement (% starch): Soybean Meal (90.23%), Limestone 
(9%), Trace Mineralized Salt (0.67%), Copper Sulfate (0.03%), Vitamin ADE (0.07%).  
b Composition of Finishing Phase Supplement (% starch): Ground Corn (84.36%), Limestone 
(11%), Urea (2.5%), Trace Mineralized Salt (1%), Thiamine (0.25%), Copper Sulfate (0.05%) 
and Vitamin ADE (0.10%) .  
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Table 6. Performance of Angus steers (n = 8/diet) in response to early weaning plus a high-
starch diet (EWS), normal weaning plus corn-grain supplement (NWS), or normal weaning 
without supplement (NWN) during the growing phase (0 to 96 d) followed by a common high-
starch diet during finishing phase (96 to 240 d) 
(Mean values and pooled standard errors)   
 
 Treatments   
 EWS NWS NWN SEM P = 
Average daily gain (ADG, kg/d)     
0 - 96 1.77a 1.55b 1.21c 0.07 0.001 
96 - 240 1.40b 1.65a 1.59a 0.07 0.06 
0 - 240 1.56 1.61 1.44 0.06 0.17 
Feed efficiency (kg/kg)*     
96 - 240 0.136b 0.164a 0.164a 0.01 0.001 
abcDifferent superscripts denote differences between treatments. 
*ADG/DM intake 
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Table 7. Ultrasound measures of ribeye area, subcutaneous and intramuscular fat deposition, and 
carcass quality parameters of Angus steers (n = 8/diet) in response to early weaning plus a high-
starch diet (EWS), normal weaning plus corn-grain supplement (NWS), or normal weaning 
without supplement (NWN) during the growing phase (0 to 96 d) followed by a common high-
starch diet during finishing phase (96 to 240 d) 
(Mean values and pooled standard errors)   
  Treatments    
 EWS NWS NWN SEM P = 
Ultrasound measurements 
At 96 d     
Back Fat (mm) 5.76 5.53 4.36 0.61 0.22 
Marbling score 401 379 413 23 0.59 
REA* (mm) 49.6a 48.6a 44.6b 1.31 0.02 
At 200 d     
Back Fat (mm) 9.02a 7.57ab 6.94b 0.64 0.05 
Marbling score 520a 514a 422b 29 0.03 
REA* (mm) 57.6 59.1 57.3 1.4 0.60 
Carcass quality 
HCW (Kg) 322 341 317 12.91 0.35 
YG 3.15a 3.22ab 2.83b 0.13 0.09 
REA (cm2) 73.3 76.7 76.8 2.6 0.53 
Marbling 580a 463b 423b 30.41 0.003 
Back fat (cm) 1.16 1.26 1.09 0.07 0.22 
KPH (%) 2.26 2.14 2.09 0.08 0.28 
abcDifferent superscripts denote differences between treatments. 
*HCW= Hot carcass weight; YG = 2.5 + (2.5 x 12th rib fat thickness in inches) + (0.0038 x hot 
carcass weight in pounds) + (0.2 x %KPH) - (0.32 x rib eye area in square inches); REA=Rib eye 
area in centimeters square; Marbling Score: 400-499 – Small; 500-599 – Modest; 600-699 – 
Moderate; KPH = Percentage kidney, pelvic, and heart fat. 
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Figure 2. Patterns of mRNA expression of Ying Yang 1 (YY1), peroxisome proliferator-activated 
receptor γ (PPARG), vitamin D receptor (VDR) and retinoic X receptor β (RXRB). Fold-changes 
in expression are expressed relative to day 0. Different superscript letters denote significant 
treatment × time interactions (P < 0.05). There was on overall effect of time (P < 0.05) on 
mRNA expression of all genes. 
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Figure 3. Patterns of mRNA expression of insulin-like growth factor binding protein 5 
(IGFBP5), signal transducer and activator of transcription 5B (STAT5B), K(lysine) 
acetyltransferase 2B (KAT2B), and general transcription factor 2B (GTF2B). Fold-changes in 
expression are expressed relative to day 0. Different superscript letters denote significant 
difference (P < 0.05) due to treatment × time interactions. There was on overall effect of time (P 
< 0.05) on mRNA expression of all genes. 
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Figure 4. Summary of YY1 gene network expression in steers comparing early weaning (EWS) 
against normal weaning without creep feeding (NWN) at 240 days on treatment. Cell location 
depicted are from the most current information in the Ingenuity Pathway Analysis® knowledge 
base. Differences in color denote expression level of genes comparing EWS and NWN 
treatments (black to grey background according with the level of expression; black color (highly 
activation) to grey color (slightly activation). All significant positive correlations (thick 
continuous lines) and non significant correlations (thin dotted lines) due to non significant 
treatment x time interaction presented both, in EWS and NWN are also included (P <0.05). 
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Appendix 
A. 1. Chromosome analysis uncovered by the Dynamic Impact Approach (DIA) based on 
DAVID (Database for Annotation, Visualization, and Integrated Discovery) database analysis of 
the bovine muscle transcriptome. Total direction represent the main flux of the metabolic 
reactions carried out by genes present in each chromosome (green color=inhibition, yellow 
color=stable, red color=activation with different color intensities according with the level of up-
regulation or down-regulation). Blue lines illustrated the impact of each time comparison for 
each chromosome and, the main impact for each chromosome as total impact (P value < 0.05; 
FDR < 0.01). 
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Results from DAVID analysis showed that Chromosome 17 presented the highest total 
impact with a flux that goes through inhibition (60 vs. 0 and 120 vs. 60) during the growing 
phase to an activation (220 vs. 120) during the finishing phase, having as a whole, an activated 
total direction (220 vs. 0). In terms of total direction, in the time comparison 220 vs. 0, 
Chromosome 19 was the one which presented the highest activation, and Chromosome Y, the 
strongest inhibition (Supplemental Table 1). When the output of DAVID is analyzed by 
performing a sort by the percentage and number of genes significantly affected in each 
chromosome and P value ; Chromosome 19 is highlighted due to the fact that it presented 131 
(7.89%) up-regulated genes (P<0.01) for the 220 vs. 0 time comparison and 127 (7.88%) up-
regulated genes for the 220 vs. 120 time comparison (P<0.01) (data not shown).   
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A. 2. Quantitative trait loci (QTLs) analysis of production related and carcass quality related 
QTLs found in chromosome BTA19 and BTA17. EEF=Ether extractable fat or percentage 
intramuscular fat, EBV=Expected Breeding Value, REA=Rib eye area, YGRADE=Yield Grade, 
BW= Body Weight, WWT= Body weight (weaning), CWT= carcass weight, FATTH= Fat 
Thickness, KPHCWT= Kidney, pelvic, and heart fat percentage, POADG= post weaning average 
daily gain (NAGRP,2011)(Hu 2010).  
 
 
 
 
 
 
 
 
 
 
  
QTLs Chromosome 19 17 
EEF 1 0 
Marbling 5 2 
Marbling (EBV) 4 1 
REA 3 2 
YGRADE 1 0 
BW 1 0 
WWT 3 1 
CWT 1 3 
FATTH 9 4 
KPHCWT 0 2 
POADG 2 1 
Total 30 16 
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A. 3. Results of the KEGG (Kyoto Encyclopedia of Genes and Genomes) most impacted 
pathways for chromosome BTA19 uncovered by the Dynamic Impact Approach (DIA) based on 
DAVID (Database for Annotation, Visualization, and Integrated Discovery) database analysis of 
the bovine muscle transcriptome. Total direction represent the main direction of the KEGG 
pathway (green color=inhibition, yellow color=stable, red color=activation with different color 
intensities according with the level of up-regulation or down-regulation). Blue lines illustrate the 
total impact of each pathway (P value < 0.05; FDR < 0.01). 
 
 
To understand why chromosome 19 had this important activation during the finishing 
phase, DIA analysis was performed on the DEG highlighted by DAVID output for chromosome 
BTA19. From this analysis, “Purine Metabolism” , “Insulin Signaling Pathway” and “Regulation 
of actin cytoskeleton” KEGG pathways were the most impacted ones. The extreme activation of 
the “Purine Metabolism” corresponds to ATP and GTP production. Also in “Insulin Signaling 
Pathway”, genes that leads to the degradation of glycogen and triacylglycerol were activated. 
The actin cytoskeleton was also one of the most affected pathways in this chromosome, with 
signs of  growth of actin filaments by means of its polymerization. Overall, glucose and energy 
supplies given by the first two mentioned pathways, promotes the implementation of the third 
one, having as a results, signs that demonstrate that  the processes that are significant for muscle 
growth were the most impacted in chromosome 19. 
BTA19 Total Total 
KEGG PATHWAYS  direction impact
bta00230:Purine metabolism
bta04910:Insulin signaling pathway
bta04810:Regulation of actin cytoskeleton
bta05010:Alzheimer's disease
bta04270:Vascular smooth muscle contraction
bta04060:Cytokine-cytokine receptor interaction
bta04012:ErbB signaling pathway
bta04020:Calcium signaling pathway
bta04062:Chemokine signaling pathway
bta04530:Tight junction
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A. 4. Top ten ranking of biological processes, cellular components and molecular functions 
uncovered by the Dynamic Impact Approach (DIA) based on DAVID (Database for Annotation, 
Visualization, and Integrated Discovery) database analysis of the bovine muscle transcriptome. 
Total direction illustrate the main direction of the Gene Ontology Term (green color=inhibition, 
yellow color=stable, red color=activation with different color intensities according with the level 
of up-regulation or down-regulation). Blue lines represent the total impact of each Gene 
Ontology Term (P value < 0.05; FDR < 0.01). 
 
The biological process domains that presented in this array higher impact were 
“Paranodal junction assembly” and “Myelin assembly”, which were both down-regulated; the 
cellular component domain that presented higher impact was “Ornithine carbamoyltransferase 
GOTERM Biological Processes Total direction Total impact
30913 Paranodal junction assembly
32288 Myelin assembly
60430 Lung saccule development
60479 Lung cell differentiation
60487 Lung epithelial cell differentiation
32435 (-) regulation of proteasomal ubiquitin-dependent protein catabolic process
51546 Keratinocyte migration
60760 Positive regulation of response to cytokine stimulus
1868 Regulation of complement activation, lectin pathway
1869 Negative regulation of complement activation, lectin pathway
GOTERM Cellular Component Total direction Total impact
9348 ornithine carbamoyltransferase complex
782 telomere cap complex
783 nuclear telomere cap complex
60170 cilium membrane
125 PCAF complex
70761 pre-snoRNP complex
5899 insulin receptor complex
16281 eukaryotic translation initiation factor 4F complex
31519 PcG protein complex
5865 striated muscle thin filament
GOTERM Molecular Function Total direction Total impact
50613 delta14-sterol reductase activity
4585 ornithine carbamoyltransferase activity
3979 UDP-glucose 6-dehydrogenase activity
42162 telomeric DNA binding
4768 stearoyl-CoA 9-desaturase activity
47760 butyrate-CoA ligase activity
4463 leukotriene-A4 hydrolase activity
4301 epoxide hydrolase activity
4765 shikimate kinase activity
47012 sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity
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complex”, being inhibited. And the molecular function domain that presented higher impact was 
“Delta14 sterol reductase activity” being also down-regulated. “Ornithine carbamoytransferase 
activity” was the second most impacted. This molecular function could has a role in 
mitochondrial protein import in skeletal muscle tissue of steers(Kalacnjuk 1995). This top ten 
analysis represent the whole output of  DAVID biological processes analysis. These GO terms 
seem to be out place if we remember that this analysis started from Longissimus thoracis et 
lumborum muscle samples. The reason why these terms are highly impacted in this array is 
because the genes that belong to each significant GO term, have high expression in another tissue 
(i.e., lung), but they are also expressed (but in less magnitude) in skeletal muscle and adipose 
tissue, where they have a different role. The selection that was performed to prepared Table 4, 
was based on the objective to be focused only in our analyzed tissue.   
116 
 
A. 5. Lipid-related biological processes by DAVID analysis. Black continued line represent the 
cutoff for significant subcategories which total impact are equal or higher than the 50% of the 
maximum total impact. Total direction illustrate the main direction of the biological process 
(green color=inhibition, yellow color=stable, red color=activation with different color intensities 
according with the level of up-regulation or down-regulation). Blue lines represent the total 
impact of each biological process (P value < 0.05; FDR < 0.01).
  
GO    Lipid-related Biological Processes Total direction Total impact
34383 low-density lipoprotein particle clearance
46460 neutral lipid biosynthetic process
46463 acylglycerol biosynthetic process
50872 white fat cell differentiation
34382 chylomicron remnant clearance
10915 regulation of very-low-density lipoprotein particle clearance
10916 negative regulation of very-low-density lipoprotein particle clearance
10985 negative regulation of lipoprotein particle clearance
32369 negative regulation of lipid transport
46339 diacylglycerol metabolic process
45923 positive regulation of fatty acid metabolic process
32371 regulation of sterol transport
6844 acyl carnitine transport
32805 positive regulation of low-density lipoprotein receptor catabolic process
34447 very-low-density lipoprotein particle clearance
10903 negative regulation of very-low-density lipoprotein particle remodeling
45598 regulation of fat cell differentiation
10894 negative regulation of steroid biosynthetic process
45939 negative regulation of steroid metabolic process
34384 high-density lipoprotein particle clearance
50996 positive regulation of lipid catabolic process
15908 fatty acid transport
10897 negative regulation of triglyceride catabolic process
10982 regulation of high-density lipoprotein particle clearance
10987 negative regulation of high-density lipoprotein particle clearance
10988 regulation of low-density lipoprotein particle clearance
10989 negative regulation of low-density lipoprotein particle clearance
10828 positive regulation of glucose transport
46326 positive regulation of glucose import
32368 regulation of lipid transport
6639 acylglycerol metabolic process
46627 negative regulation of insulin receptor signaling pathway
32024 positive regulation of insulin secretion
55088 lipid homeostasis
6641 triglyceride metabolic process
60191 regulation of lipase activity
6638 neutral lipid metabolic process
46461 neutral lipid catabolic process
46464 acylglycerol catabolic process
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A. 5. Continued 
  
46503 glycerolipid catabolic process
50994 regulation of lipid catabolic process
34369 plasma lipoprotein particle remodeling
8286 insulin receptor signaling pathway
42159 lipoprotein catabolic process
46626 regulation of insulin receptor signaling pathway
45834 positive regulation of lipid metabolic process
19217 regulation of fatty acid metabolic process
15909 long-chain fatty acid transport
45723 positive regulation of fatty acid biosynthetic process
9062 fatty acid catabolic process
32098 regulation of appetite
43550 regulation of lipid kinase activity
10896 regulation of triglyceride catabolic process
45833 negative regulation of lipid metabolic process
45599 negative regulation of fat cell differentiation
10873 positive regulation of cholesterol esterification
32309 icosanoid secretion
50482 arachidonic acid secretion
10898 positive regulation of triglyceride catabolic process
42304 regulation of fatty acid biosynthetic process
51055 negative regulation of lipid biosynthetic process
32370 positive regulation of lipid transport
19395 fatty acid oxidation
34440 lipid oxidation
34377 plasma lipoprotein particle assembly
10890 positive regulation of sequestering of triglyceride
19216 regulation of lipid metabolic process
50995 negative regulation of lipid catabolic process
6633 fatty acid biosynthetic process
32868 response to insulin stimulus
6631 fatty acid metabolic process
44242 cellular lipid catabolic process
32803 regulation of low-density lipoprotein receptor catabolic process
30497 fatty acid elongation
46889 positive regulation of lipid biosynthetic process
45717 negative regulation of fatty acid biosynthetic process
45922 negative regulation of fatty acid metabolic process
46890 regulation of lipid biosynthetic process
48385 regulation of retinoic acid receptor signaling pathway
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A. 5. Continued 
 
  
6636 unsaturated fatty acid biosynthetic process
46456 icosanoid biosynthetic process
33559 unsaturated fatty acid metabolic process
1676 long-chain fatty acid metabolic process
42759 long-chain fatty acid biosynthetic process
42158 lipoprotein biosynthetic process
30258 lipid modification
51790 short-chain fatty acid biosynthetic process
51791 medium-chain fatty acid metabolic process
10878 cholesterol storage
10889 regulation of sequestering of triglyceride
10884 positive regulation of lipid storage
32365 intracellular lipid transport
32366 intracellular sterol transport
31058 positive regulation of histone modification
30730 sequestering of triglyceride
30259 lipid glycosylation
10891 negative regulation of sequestering of triglyceride
46459 short-chain fatty acid metabolic process
46834 lipid phosphorylation
10888 negative regulation of lipid storage
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A. 6. Gene expression-related biological processes by DAVID analysis. Black continued line 
represent the cutoff for significant subcategories which total impact are equal or higher than the 
50% of the maximum total impact. Total direction illustrate the main direction of the biological 
process (green color=inhibition, yellow color=stable, red color=activation with different color 
intensities according with the level of up-regulation or down-regulation). Blue lines represent the 
total impact of each biological process (P value < 0.05; FDR < 0.01). 
  
GO    Gene expression-related biological processes Total direction Total impact
32922 circadian regulation of gene expression
45899 positive regulation of transcriptional preinitiation complex assembly
45980 negative regulation of nucleotide metabolic process
54 ribosome export from nucleus
56 ribosomal small subunit export from nucleus
33753 establishment of ribosome localization
32392 DNA geometric change
45740 positive regulation of DNA replication
6354 RNA elongation
70424 regulation of nucleotide-binding oligomerization domain containing signaling pathway
70426 positive regulation of nucleotide-binding oligomerization domain containing signaling pathway
70428 regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
70430 positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
70432 regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
70434 positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
42307 positive regulation of protein import into nucleus
42993 positive regulation of transcription factor import into nucleus
43487 regulation of RNA stability
32909 regulation of transforming growth factor-beta2 production
45911 positive regulation of DNA recombination
30511 positive regulation of transforming growth factor beta receptor signaling pathway
51051 negative regulation of transport
45727 positive regulation of translation
6449 regulation of translational termination
45905 positive regulation of translational termination
45815 positive regulation of gene expression, epigenetic
43618 regulation of transcription from RNA polymerase II promoter in response to stress
43619 regulation of transcription from RNA polymerase II promoter in response to oxidative stress
51054 positive regulation of DNA metabolic process
6270 DNA replication initiation
31061 negative regulation of histone methylation
6275 regulation of DNA replication
6414 translational elongation
30809 negative regulation of nucleotide biosynthetic process
9219 pyrimidine deoxyribonucleotide metabolic process
50684 regulation of mRNA processing
17148 negative regulation of translation
9142 nucleoside triphosphate biosynthetic process
43484 regulation of RNA splicing
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A. 6. Continued 
6352 transcription initiation
379 tRNA-type intron splice site recognition and cleavage
6406 mRNA export from nucleus
17015 regulation of transforming growth factor beta receptor signaling pathway
7172 signal complex assembly
18 regulation of DNA recombination
45814 negative regulation of gene expression, epigenetic
6408 snRNA export from nucleus
51030 snRNA transport
9968 negative regulation of signal transduction
6351 transcription, DNA-dependent
34655 nucleobase, nucleoside, nucleotide and nucleic acid catabolic process
34656 nucleobase, nucleoside and nucleotide catabolic process
19932 second-messenger-mediated signaling
34404 nucleobase, nucleoside and nucleotide biosynthetic process
34654 nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process
45885 positive regulation of survival gene product expression
32774 RNA biosynthetic process
9150 purine ribonucleotide metabolic process
6405 RNA export from nucleus
6412 translation
10628 positive regulation of gene expression
45935 positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
6265 DNA topological change
6260 DNA replication
9967 positive regulation of signal transduction
30808 regulation of nucleotide biosynthetic process
22401 adaptation of signaling pathway
6417 regulation of translation
51052 regulation of DNA metabolic process
6376 mRNA splice site selection
9966 regulation of signal transduction
45893 positive regulation of transcription, DNA-dependent
51254 positive regulation of RNA metabolic process
6308 DNA catabolic process
6309 DNA fragmentation involved in apoptosis
10608 posttranscriptional regulation of gene expression
16481 negative regulation of transcription
15860 purine nucleoside transport
45934 negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
10629 negative regulation of gene expression
31056 regulation of histone modification
45892 negative regulation of transcription, DNA-dependent
51253 negative regulation of RNA metabolic process
6206 pyrimidine base metabolic process
40029 regulation of gene expression, epigenetic
32409 regulation of transporter activity
50657 nucleic acid transport
50658 RNA transport
31057 negative regulation of histone modification
6401 RNA catabolic process
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45739 positive regulation of DNA repair
30512 negative regulation of transforming growth factor beta receptor signaling pathway
15074 DNA integration
6310 DNA recombination
10468 regulation of gene expression
6259 DNA metabolic process
19219 regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
16071 mRNA metabolic process
45449 regulation of transcription
9124 nucleoside monophosphate biosynthetic process
6457 protein folding
45884 regulation of survival gene product expression
43388 positive regulation of DNA binding
16458 gene silencing
6281 DNA repair
6397 mRNA processing
16070 RNA metabolic process
19363 pyridine nucleotide biosynthetic process
42770 DNA damage response, signal transduction
6221 pyrimidine nucleotide biosynthetic process
43242 negative regulation of protein complex disassembly
19362 pyridine nucleotide metabolic process
51252 regulation of RNA metabolic process
8380 RNA splicing
6355 regulation of transcription, DNA-dependent
31062 positive regulation of histone methylation
51090 regulation of transcription factor activity
35067 negative regulation of histone acetylation
6282 regulation of DNA repair
31570 DNA integrity checkpoint
6396 RNA processing
6413 translational initiation
51028 mRNA transport
6418 tRNA aminoacylation for protein translation
6415 translational termination
34660 ncRNA metabolic process
9451 RNA modification
34470 ncRNA processing
16246 RNA interference
35196 gene silencing by miRNA, production of miRNAs
154 rRNA modification
43392 negative regulation of DNA binding
6269 DNA replication, synthesis of RNA primer
9218 pyrimidine ribonucleotide metabolic process
31123 RNA 3'-end processing
35195 gene silencing by miRNA
15858 nucleoside transport
30422 RNA interference, production of siRNA
6304 DNA modification
65004 protein-DNA complex assembly
51053 negative regulation of DNA metabolic process
